Altering cell death pathways as an approach to cure HIV infection

Recent cases of successful control of human immunodeficiency virus (HIV) by bone marrow transplant in combination with suppressive antiretroviral therapy (ART) and very early initiation of ART have provided proof of concept that HIV infection might now be cured. Current efforts focusing on gene ther...

Full description

Saved in:
Bibliographic Details
Published inCell death & disease Vol. 4; no. 7; p. e718
Main Authors Badley, A D, Sainski, A, Wightman, F, Lewin, S R
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.07.2013
Springer Nature B.V
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Recent cases of successful control of human immunodeficiency virus (HIV) by bone marrow transplant in combination with suppressive antiretroviral therapy (ART) and very early initiation of ART have provided proof of concept that HIV infection might now be cured. Current efforts focusing on gene therapy, boosting HIV-specific immunity, reducing inflammation and activation of latency have all been the subject of recent excellent reviews. We now propose an additional avenue of research towards a cure for HIV: targeting HIV apoptosis regulatory pathways. The central enigma of HIV disease is that HIV infection kills most of the CD4 T cells that it infects, but those cells that are spared subsequently become a latent reservoir for HIV against which current medications are ineffective. We propose that if strategies could be devised which would favor the death of all cells which HIV infects, or if all latently infected cells that release HIV would succumb to viral-induced cytotoxicity, then these approaches combined with effective ART to prevent spreading infection, would together result in a cure for HIV. This premise is supported by observations in other viral systems where the relationship between productive infection, apoptosis resistance, and the development of latency or persistence has been established. Therefore we propose that research focused at understanding the mechanisms by which HIV induces apoptosis of infected cells, and ways that some cells escape the pro-apoptotic effects of productive HIV infection are critical to devising novel and rational approaches to cure HIV infection.
AbstractList Recent cases of successful control of human immunodeficiency virus (HIV) by bone marrow transplant in combination with suppressive antiretroviral therapy (ART) and very early initiation of ART have provided proof of concept that HIV infection might now be cured. Current efforts focusing on gene therapy, boosting HIV-specific immunity, reducing inflammation and activation of latency have all been the subject of recent excellent reviews. We now propose an additional avenue of research towards a cure for HIV: targeting HIV apoptosis regulatory pathways. The central enigma of HIV disease is that HIV infection kills most of the CD4 T cells that it infects, but those cells that are spared subsequently become a latent reservoir for HIV against which current medications are ineffective. We propose that if strategies could be devised which would favor the death of all cells which HIV infects, or if all latently infected cells that release HIV would succumb to viral-induced cytotoxicity, then these approaches combined with effective ART to prevent spreading infection, would together result in a cure for HIV. This premise is supported by observations in other viral systems where the relationship between productive infection, apoptosis resistance, and the development of latency or persistence has been established. Therefore we propose that research focused at understanding the mechanisms by which HIV induces apoptosis of infected cells, and ways that some cells escape the pro-apoptotic effects of productive HIV infection are critical to devising novel and rational approaches to cure HIV infection.
Recent cases of successful control of human immunodeficiency virus (HIV) by bone marrow transplant in combination with suppressive antiretroviral therapy (ART) and very early initiation of ART have provided proof of concept that HIV infection might now be cured. Current efforts focusing on gene therapy, boosting HIV-specific immunity, reducing inflammation and activation of latency have all been the subject of recent excellent reviews. We now propose an additional avenue of research towards a cure for HIV: targeting HIV apoptosis regulatory pathways. The central enigma of HIV disease is that HIV infection kills most of the CD4 T cells that it infects, but those cells that are spared subsequently become a latent reservoir for HIV against which current medications are ineffective. We propose that if strategies could be devised which would favor the death of all cells which HIV infects, or if all latently infected cells that release HIV would succumb to viral-induced cytotoxicity, then these approaches combined with effective ART to prevent spreading infection, would together result in a cure for HIV. This premise is supported by observations in other viral systems where the relationship between productive infection, apoptosis resistance, and the development of latency or persistence has been established. Therefore we propose that research focused at understanding the mechanisms by which HIV induces apoptosis of infected cells, and ways that some cells escape the pro-apoptotic effects of productive HIV infection are critical to devising novel and rational approaches to cure HIV infection.Recent cases of successful control of human immunodeficiency virus (HIV) by bone marrow transplant in combination with suppressive antiretroviral therapy (ART) and very early initiation of ART have provided proof of concept that HIV infection might now be cured. Current efforts focusing on gene therapy, boosting HIV-specific immunity, reducing inflammation and activation of latency have all been the subject of recent excellent reviews. We now propose an additional avenue of research towards a cure for HIV: targeting HIV apoptosis regulatory pathways. The central enigma of HIV disease is that HIV infection kills most of the CD4 T cells that it infects, but those cells that are spared subsequently become a latent reservoir for HIV against which current medications are ineffective. We propose that if strategies could be devised which would favor the death of all cells which HIV infects, or if all latently infected cells that release HIV would succumb to viral-induced cytotoxicity, then these approaches combined with effective ART to prevent spreading infection, would together result in a cure for HIV. This premise is supported by observations in other viral systems where the relationship between productive infection, apoptosis resistance, and the development of latency or persistence has been established. Therefore we propose that research focused at understanding the mechanisms by which HIV induces apoptosis of infected cells, and ways that some cells escape the pro-apoptotic effects of productive HIV infection are critical to devising novel and rational approaches to cure HIV infection.
Author Badley, A D
Lewin, S R
Wightman, F
Sainski, A
Author_xml – sequence: 1
  givenname: A D
  surname: Badley
  fullname: Badley, A D
  email: badley.andrew@mayo.edu
  organization: Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Department of Molecular Medicine, Mayo Clinic
– sequence: 2
  givenname: A
  surname: Sainski
  fullname: Sainski, A
  organization: Department of Molecular Medicine, Mayo Clinic, Department of Molecular Pharmacology, Mayo Clinic
– sequence: 3
  givenname: F
  surname: Wightman
  fullname: Wightman, F
  organization: Department of Infectious Diseases, Alfred Hospital and Monash University, Centre for Biomedical Research, Burnet Institute
– sequence: 4
  givenname: S R
  surname: Lewin
  fullname: Lewin, S R
  organization: Department of Infectious Diseases, Alfred Hospital and Monash University, Centre for Biomedical Research, Burnet Institute
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23846220$$D View this record in MEDLINE/PubMed
BookMark eNqFUc9rFDEYDVKxtfbqUQJevOz2y4-ZJBdhKWoLBS_qNWSSTDdlNhmTmUr_ezNuLWtRDPkF33sv78t7iY5iih6h1wTWBJg8t86FsqZA2Jpy-QydUOBkxaVURwf3Y3RWyi3UwRjQpn2BjimTvKUUTtBmM0w-h3iDrR8G7LyZtnis2w9zX7CpM2IzjjkZu8VTwnbOHl9efcMh9t5OIcVX6HlvhuLPHs5T9PXjhy8Xl6vrz5-uLjbXK9s0Ylq1pKdgOGWuZapVjveScyM74KKxjEjoVNe1TAgKnROiFsA75wUznTV1sVP0fq87zt3OO-vjlM2gxxx2Jt_rZIL-sxLDVt-kO80EA05JFXj3IJDT99mXSe9CWbo20ae5aCIUKE4a4P-HMqUU40Q0Ffr2CfQ2zTnWn6iCsqUglVrefnNo_tH17yAqYL0H2JxKyb5_hBDQS9j6V9h6CVvXsCuBPyHYMJklkNp8GP5NO9_Tyrik7vOB3b8zfgIiSbyp
CitedBy_id crossref_primary_10_1038_nm_4124
crossref_primary_10_3389_fmicb_2017_02007
crossref_primary_10_3389_fmicb_2019_02828
crossref_primary_10_3390_medicina55060297
crossref_primary_10_1016_j_omtn_2021_02_004
crossref_primary_10_1128_JVI_00012_17
crossref_primary_10_1016_j_crmeth_2021_100122
crossref_primary_10_1073_pnas_1818662116
crossref_primary_10_1111_voxs_12136
crossref_primary_10_1038_cddis_2013_473
crossref_primary_10_1097_QAD_0000000000003908
crossref_primary_10_1099_jgv_0_000402
crossref_primary_10_1172_JCI80564
crossref_primary_10_1089_aid_2018_0153
crossref_primary_10_1186_2052_8426_2_10
crossref_primary_10_3389_fimmu_2015_00506
crossref_primary_10_1186_s12977_018_0448_8
crossref_primary_10_1016_j_mayocp_2015_03_008
crossref_primary_10_3389_fmicb_2018_02022
crossref_primary_10_1097_COH_0000000000000279
crossref_primary_10_1089_aid_2019_0213
crossref_primary_10_3390_v6083181
crossref_primary_10_1007_s40265_015_0426_6
crossref_primary_10_1016_j_isci_2024_110324
crossref_primary_10_1016_j_immuni_2018_04_004
crossref_primary_10_3389_fimmu_2023_1096759
crossref_primary_10_1016_j_ijantimicag_2019_08_001
crossref_primary_10_1186_s12977_019_0494_x
crossref_primary_10_1080_14786419_2019_1619720
crossref_primary_10_1155_2016_8910396
crossref_primary_10_1007_s11908_014_0392_2
crossref_primary_10_1128_JVI_02092_16
crossref_primary_10_1016_j_tim_2015_11_003
crossref_primary_10_1038_s41579_023_00914_1
crossref_primary_10_1172_JCI159569
crossref_primary_10_1038_s41586_022_04597_1
crossref_primary_10_1016_j_jinorgbio_2022_112117
crossref_primary_10_1186_s12977_015_0169_1
crossref_primary_10_1038_s41434_023_00413_1
crossref_primary_10_1016_j_bbrc_2015_02_102
crossref_primary_10_1128_JVI_03179_15
crossref_primary_10_1038_srep36111
crossref_primary_10_1038_s41598_020_60614_1
crossref_primary_10_1128_JVI_00231_16
crossref_primary_10_1038_s41598_017_12758_w
crossref_primary_10_1080_15548627_2020_1831814
crossref_primary_10_1371_journal_ppat_1004071
crossref_primary_10_3390_molecules200814051
crossref_primary_10_1586_14787210_2014_956094
crossref_primary_10_1186_s12859_019_2990_3
crossref_primary_10_1371_journal_ppat_1004156
crossref_primary_10_3390_v6041837
Cites_doi 10.4049/jimmunol.165.6.3293
10.1016/j.virol.2010.12.041
10.1126/science.3313729
10.1186/1743-422X-7-266
10.1186/1742-4690-6-52
10.1073/pnas.1002894107
10.2174/1570162033485203
10.1074/jbc.M112.408294
10.1186/1743-422X-8-554
10.1097/QAD.0b013e328330342c
10.1038/362359a0
10.1128/JVI.79.7.4510-4513.2005
10.1093/cid/cis383
10.1084/jem.187.3.403
10.1128/JVI.01350-09
10.1084/jem.182.4.1067
10.1016/j.coi.2009.02.009
10.1038/cddis.2010.77
10.1189/jlb.0312165
10.1126/science.1195271
10.1371/journal.pone.0006093
10.1056/NEJMoa0802905
10.1038/nature11286
10.1038/nrc2889
10.1182/blood-2010-09-309591
10.1016/S0092-8674(00)80110-5
10.1126/scitranslmed.3000931
10.1093/infdis/jis630
10.1371/journal.pone.0030176
10.1007/s00262-011-1008-4
10.1128/JVI.00793-12
10.2174/157016210793499312
10.1039/C1MB05386H
10.1016/j.bbrc.2011.09.007
10.1128/JVI.79.5.3139-3145.2005
10.1016/j.virol.2009.04.019
10.4049/jimmunol.1102483
10.1128/JVI.00249-06
10.1128/JVI.76.17.8776-8786.2002
10.1038/382722a0
10.1128/JVI.02033-10
10.1159/000100565
10.1182/blood-2007-06-097907
10.1128/JVI.78.11.6033-6042.2004
10.1517/14728214.2010.515210
10.1182/blood-2011-04-348540
10.1038/nbt1410
10.1038/mt.2011.310
10.1093/annonc/mdq009
10.1128/JVI.00161-10
10.1097/QAD.0b013e32835535f5
10.1371/journal.ppat.1000018
10.1038/sj.emboj.7600900
10.1089/aid.2008.0191
10.1038/nm0397-333
10.1016/j.febslet.2011.10.018
10.1097/QAI.0b013e3181d3dca3
10.1371/journal.ppat.1002288
10.1074/jbc.M110.180224
10.1097/QAD.0b013e328347bd77
10.1038/sj.emboj.7601074
10.1097/QAD.0b013e32832ec1dc
10.1038/ng2035
10.4049/jimmunol.175.3.1551
10.1016/j.vaccine.2011.09.118
10.1128/JVI.80.9.4570-4579.2006
10.1073/pnas.86.15.5974
10.1074/jbc.M111.274639
10.1186/1742-4690-8-80
10.1038/nri3262
10.1038/nature10660
10.4049/jimmunol.180.1.350
10.1371/journal.pone.0048340
10.1182/blood-2008-10-186601
10.1038/44755
10.1097/QAD.0b013e328333bfa1
10.1038/nri3173
10.1371/journal.pone.0048832
10.1016/j.chom.2008.06.008
10.1016/j.virol.2012.06.025
10.1371/journal.pbio.0030404
10.1146/annurev.immunol.18.1.665
10.1097/QAD.0b013e328340fe28
10.1186/1743-422X-9-149
10.1212/WNL.44.3_Part_1.481
10.1093/emboj/cdg188
10.1002/jcb.20532
10.1371/journal.pone.0002112
10.4049/jimmunol.171.3.1172
10.1172/JCI200522574
10.1038/8394
10.1038/387183a0
10.1016/j.immuni.2008.10.010
10.1074/jbc.M606324200
10.1128/JVI.02798-06
10.1016/j.cyto.2009.08.010
10.1158/1078-0432.CCR-08-0746
10.1371/journal.pmed.1000321
10.1038/sj.cdd.4400509
10.1038/385645a0
10.1128/JVI.02536-10
10.1073/pnas.84.9.2985
10.1074/jbc.M110.195537
10.4049/jimmunol.181.11.7713
10.1126/scitranslmed.3003761
10.1016/j.febslet.2011.03.017
10.1086/527324
10.2174/157488812800793108
10.1086/656721
10.4049/jimmunol.1100275
10.1371/journal.ppat.1003211
10.1016/j.immuni.2012.01.014
10.1038/34814
10.1097/QAI.0b013e3182895af4
10.1126/science.273.5283.1856
10.1016/j.ymthe.2005.07.524
10.1001/archinternmed.2012.2719
10.1038/333426a0
10.1615/CritRevImmunol.v32.i2.50
10.1186/1742-4690-5-19
10.1371/journal.ppat.1004071
10.1097/QAD.0b013e32835ecb8b
10.1186/1758-2652-13-S3-O15
10.1128/JVI.72.12.9698-9705.1998
10.1016/S0021-9258(19)75998-5
10.1016/j.ygeno.2012.11.008
ContentType Journal Article
Copyright The Author(s) 2013
Copyright Nature Publishing Group Jul 2013
Copyright © 2013 Macmillan Publishers Limited 2013 Macmillan Publishers Limited
Copyright_xml – notice: The Author(s) 2013
– notice: Copyright Nature Publishing Group Jul 2013
– notice: Copyright © 2013 Macmillan Publishers Limited 2013 Macmillan Publishers Limited
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88A
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M2P
M7P
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
7TO
7U9
H94
5PM
DOI 10.1038/cddis.2013.248
DatabaseName SpringerOpen Free (Free internet resource, activated by CARLI)
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
Oncogenes and Growth Factors Abstracts
AIDS and Cancer Research Abstracts
Virology and AIDS Abstracts
DatabaseTitleList

Publicly Available Content Database
MEDLINE - Academic
CrossRef
Oncogenes and Growth Factors Abstracts
MEDLINE
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Apoptosis modulation and HIV cure
EISSN 2041-4889
EndPage e718
ExternalDocumentID PMC3730421
4042531961
23846220
10_1038_cddis_2013_248
Genre Review
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: R56 AI095073
– fundername: NIAID NIH HHS
  grantid: U19 AI096109
– fundername: NIAID NIH HHS
  grantid: R01 AI110173
– fundername: NIAID NIH HHS
  grantid: 1R56AI095073-01A1
– fundername: NIGMS NIH HHS
  grantid: T32 GM072474
– fundername: NIAID NIH HHS
  grantid: R01 AI040384
GroupedDBID ---
0R~
3V.
53G
5VS
70F
7X7
88A
88I
8FE
8FH
8FI
8FJ
AAJSJ
ABAWZ
ABUWG
ACGFS
ACSMW
ADBBV
ADRAZ
AENEX
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CAG
CCPQU
COF
DIK
DWQXO
E3Z
EBLON
EBS
EJD
EMOBN
FRP
FYUFA
GNUQQ
GROUPED_DOAJ
HCIFZ
HMCUK
HYE
HZ~
IPNFZ
KQ8
LK8
M0L
M2P
M48
M7P
M~E
NAO
O5R
O5S
O9-
OK1
PIMPY
PQQKQ
PROAC
RIG
RNT
RPM
SNYQT
TR2
UKHRP
W2D
AASML
AAYXX
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
PQGLB
7XB
8FK
AARCD
K9.
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
7TO
7U9
H94
5PM
ID FETCH-LOGICAL-c557t-61f20a423d63969d4f844a8b0475c3180b9bb637720bd778b00edde73abcaabc3
IEDL.DBID 7X7
ISSN 2041-4889
IngestDate Thu Aug 21 18:25:35 EDT 2025
Tue Aug 05 10:47:41 EDT 2025
Fri Jul 11 11:58:07 EDT 2025
Wed Aug 13 10:00:38 EDT 2025
Mon Jul 21 06:04:49 EDT 2025
Tue Jul 01 01:10:36 EDT 2025
Thu Apr 24 23:03:09 EDT 2025
Fri Feb 21 02:36:55 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords Bcl2
apoptosis
HIV cure
Casp8p41
latency
Language English
License This work is licensed under a Creative Commons Attribution 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c557t-61f20a423d63969d4f844a8b0475c3180b9bb637720bd778b00edde73abcaabc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
OpenAccessLink https://www.proquest.com/docview/1786208991?pq-origsite=%requestingapplication%
PMID 23846220
PQID 1786208991
PQPubID 2041963
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3730421
proquest_miscellaneous_1790941504
proquest_miscellaneous_1399934175
proquest_journals_1786208991
pubmed_primary_23846220
crossref_primary_10_1038_cddis_2013_248
crossref_citationtrail_10_1038_cddis_2013_248
springer_journals_10_1038_cddis_2013_248
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-07-01
PublicationDateYYYYMMDD 2013-07-01
PublicationDate_xml – month: 07
  year: 2013
  text: 2013-07-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Cell death & disease
PublicationTitleAbbrev Cell Death Dis
PublicationTitleAlternate Cell Death Dis
PublicationYear 2013
Publisher Nature Publishing Group UK
Springer Nature B.V
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Springer Nature B.V
– name: Nature Publishing Group
References Stremlau, Perron, Welikala, Sodroski (CR72) 2005; 79
Hutter, Thiel (CR3) 2011; 25
Allers, Hutter, Hofmann, Loddenkemper, Rieger, Thiel (CR1) 2010; 117
Duh, Maury, Folks, Fauci, Rabson (CR35) 1989; 86
Sayers (CR107) 2011; 60
Scholler, Brady, Binder-Scholl, Hwang, Plesa, Hege (CR77) 2012; 4
Saleh, Wightman, Ramanayake, Alexander, Kumar, Khoury (CR130) 2011; 8
Migueles, Osborne, Royce, Compton, Joshi, Weeks (CR85) 2008; 29
Lodi, Meyer, Kelleher, Rosinska, Ghosn, Sannes (CR61) 2012; 172
Yuan, Wang, Crain, Fearns, Kim, Hua (CR70) 2012; 20
Chun, Davey, Engel, Lane, Fauci (CR91) 1999; 401
Gyrd-Hansen, Meier (CR103) 2010; 10
Lum, Badley (CR13) 2003; 1
Bren, Whitman, Cummins, Shepard, Rizza, Trushin (CR53) 2008; 3
Levy, Sereti, Tambussi, Routy, Lelievre, Delfraissy (CR94) 2012; 55
Reddy, Czuczman (CR104) 2010; 21
CR49
Dean, Carrington, Winkler, Huttley, Smith, Allikmets (CR80) 1996; 273
Lopez-Huertas, Mateos, Sanchez Del Cojo, Gomez-Esquer, Diaz-Gil, Rodriguez-Mora (CR15) 2013; 288
Saez-Cirion, Bacchus, Hocqueloux, Avettand-Fenoel, Girault, Lecuroux (CR60) 2013; 9
Perez, Wang, Miller, Jouvenot, Kim, Liu (CR69) 2008; 26
Chehimi, Papasavvas, Tomescu, Gekonge, Abdulhaqq, Raymond (CR19) 2010; 84
Sereti, Dunham, Spritzler, Aga, Proschan, Medvik (CR93) 2009; 113
Balazs, Chen, Hong, Rao, Yang, Baltimore (CR73) 2012; 481
Gandhi, Zheng, Bosch, Chan, Margolis, Read (CR89) 2010; 7
Klichko, Archin, Kaur, Lehrman, Margolis (CR132) 2006; 80
Dokmanovic, Marks (CR40) 2005; 96
Mita, Mita, Nawrocki, Giles (CR105) 2008; 14
Cho, Roche, Sandall, Brass, Seed, Xavier (CR7) 2012; 189
Zheng, Yang, Guocai, Pauza, Salvato (CR18) 2007; 50
Cummins, Badley (CR55) 2010; 1
Savarino, Mai, Norelli, El Daker, Valente, Rotili (CR118) 2009; 6
Hutter, Nowak, Mossner, Ganepola, Mussig, Allers (CR2) 2009; 360
Badley, Parato, Cameron, Kravcik, Phenix, Ashby (CR14) 1999; 6
Wightman, Solomon, Khoury, Green, Gray, Gorry (CR26) 2010; 202
Lai (CR71) 2012; 7
Tornatore, Chandra, Berger, Major (CR28) 1994; 44
Chinnaiyan, Woffendin, Dixit, Nabel (CR50) 1997; 3
Archin, Liberty, Kashuba, Choudhary, Kuruc, Crooks (CR63) 2012; 487
Shehu-Xhilaga, Rhodes, Wightman, Liu, Solomon, Saleh (CR66) 2009; 23
Pallikkuth, Rogers, Villinger, Dosterii, Vaccari, Franchini (CR99) 2011; 29
Archin, Keedy, Espeseth, Dang, Hazuda, Margolis (CR120) 2009; 23
CR137
CR138
Strauss, Knape, Melzner, Debatin (CR109) 2003; 171
Guidi, Puglia, Gabbiani, Landini, Gamberi, Fregona (CR114) 2012; 8
Levy, Lacabaratz, Weiss, Viard, Goujard, Lelievre (CR92) 2009; 119
Kutsch, Benveniste, Shaw, Levy (CR38) 2002; 76
Banerjee, Archin, Michaels, Belkina, Denis, Bradner (CR135) 2012; 92
Han, Li, Chen, Wang, Mei, Wu (CR10) 2012; 7
Schnepple, Shepard, Bren, Cummins, Natesampillai, Trushin (CR20) 2011; 286
Nie, Bren, Vlahakis, Schimnich, Brenchley, Trushin (CR108) 2007; 81
Loetscher, Uguccioni, Bordoli, Baggiolini, Moser, Chizzolini (CR57) 1998; 391
Unsoeld, Pircher (CR56) 2005; 79
CR65
CR64
CR62
Martin, Qi, Gao, Yamada, Martin, Pereyra (CR84) 2007; 39
Chun, Carruth, Finzi, Shen, DiGiuseppe, Taylor (CR39) 1997; 387
Lam, Yeung, Chan (CR9) 2011; 8
Lewis, DaFonseca, Chomont, Palamara, Tardugno, Mai (CR115) 2011; 25
Ying, Zhang, Zhou, Qu, Wang, Liu (CR125) 2012; 7
Azmi, Wang, Philip, Mohammad, Sarkar (CR102) 2011; 16
Jordan, Bisgrove, Verdin (CR37) 2003; 22
Lopez-Huertas, Mateos, Sanchez Del Cojo, Gomez-Esquer, Diaz-Gil, Rodriguez-Mora (CR21) 2013; 288
Taiwo, Hunt, Gandhi, Ellingson, McKenna, Jacobson (CR88) 2013; 63
Pallikkuth, Parmigiani, Pahwa (CR98) 2012; 32
Treand, du Chene, Bres, Kiernan, Benarous, Benkirane (CR32) 2006; 25
Shan, Yang, Rabi, Bravo, Shroff, Irizarry (CR41) 2011; 85
Archin, Espeseth, Parker, Cheema, Hazuda, Margolis (CR48) 2009; 25
Xing, Bullen, Shroff, Shan, Yang, Manucci (CR134) 2011; 85
Mukherjee, Majumdar, Vipat, Mishra, Chakrabarti (CR8) 2012; 9
Cameron, Saleh, Sallmann, Solomon, Wightman, Evans (CR45) 2010; 107
Montefiori, Mitchell (CR113) 1987; 84
Brentjens, Riviere, Park, Davila, Wang, Stefanski (CR76) 2011; 118
DiGiusto, Krishnan, Li, Li, Li, Rao (CR79) 2010; 2
Bernhard, Barreto, Saunders, Dahabieh, Johnson, Sadowski (CR128) 2011; 585
Galluzzi, Brenner, Morselli, Touat, Kroemer (CR11) 2008; 4
Sadelain, Brentjens, Riviere (CR75) 2009; 21
Lum, Schnepple, Nie, Sanchez-Dardon, Mbisa, Mihowich (CR96) 2004; 78
Liu, Paxton, Choe, Ceradini, Martin, Horuk (CR81) 1996; 86
Shan, Deng, Shroff, Durand, Rabi, Yang (CR67) 2012; 36
Mueller, Do, Altork, Artlett, Gracely, Katsetos (CR97) 2008; 180
Bouchat, Gatot, Kabeya, Cardona, Colin, Herbein (CR127) 2012; 26
Pereyra, Jia, McLaren, Telenti, de Bakker, Walker (CR83) 2010; 330
CR6
Altmann, Hammerschmidt (CR12) 2005; 3
Marini, Harper, Romerio (CR42) 2008; 181
Bosque, Famiglietti, Weyrich, Goulston, Planelles (CR68) 2011; 7
CR86
CR124
Fernandez, Zeichner (CR126) 2010; 7
Reuse, Calao, Kabeya, Guiguen, Gatot, Quivy (CR117) 2009; 4
Saleh, Solomon, Wightman, Xhilaga, Cameron, Lewin (CR46) 2007; 110
Conti, Matarrese, Varano, Gauzzi, Sato, Malorni (CR100) 2000; 165
Caron, Duluc, Fremaux, Jeannin, David, Gascan (CR111) 2005; 175
Hatano, Jain, Hunt, Lee, Sinclair, Do (CR87) 2012; 208
Burnett, Lim, Calafi, Rossi, Schaffer, Arkin (CR43) 2010; 84
Thibault, Imbeault, Tardif, Tremblay (CR112) 2009; 389
CR129
Aillet, Masutani, Elbim, Raoul, Chene, Nugeyre (CR51) 1998; 72
Rasmussen, Schmeltz Sogaard, Brinkmann, Wightman, Lewin, Melchjorsen (CR123) 2013; 9
Deeks, Autran, Berkhout, Benkirane, Cairns, Chomont (CR30) 2012; 12
Choi, Lee, Oh, Hyun, Ro, Kim (CR119) 2010; 24
Samson, Libert, Doranz, Rucker, Liesnard, Farber (CR82) 1996; 382
Weis, Brown, Cusack, Paulson, Skehel, Wiley (CR5) 1988; 333
Zaunders, Ip, Munier, Kaufmann, Suzuki, Brereton (CR58) 2006; 80
Perez, de Vinuesa, Sanchez-Duffhues, Marquez, Bellido, Munoz-Fernandez (CR131) 2010; 8
Chun, Nickle, Justement, Meyers, Roby, Hallahan (CR24) 2008; 197
Lassen, Hebbeler, Bhattacharyya, Lobritz, Greene (CR44) 2012; 7
Veselinovic, Neff, Mulder, Akkina (CR74) 2012; 432
Berro, de la Fuente, Klase, Kehn, Parvin, Pumfery (CR17) 2007; 282
Finzi, Blankson, Siliciano, Margolick, Chadwick, Pierson (CR22) 1999; 5
Embretson, Zupancic, Ribas, Burke, Racz, Tenner-Racz (CR25) 1993; 362
Matalon, Palmer, Nold, Furlan, Kassu, Fossati (CR121) 2010; 54
He, Chen, Farzan, Choe, Ohagen, Gartner (CR29) 1997; 385
Conti, Rainaldi, Matarrese, Varano, Rivabene, Columba (CR16) 1998; 187
Folks, Justement, Kinter, Dinarello, Fauci (CR36) 1987; 238
Pierson, McArthur, Siliciano (CR23) 2000; 18
CR90
Spiegel, Herbst, Niedobitek, Foss, Stein (CR27) 1992; 140
Shishido, Wolschendorf, Duverger, Wagner, Kappes, Jones (CR133) 2012; 86
Suzuki, Nagao, Kato, Matsumoto, Nerome, Nakajima (CR4) 1986; 261
Seder, Grabstein, Berzofsky, McDyer (CR95) 1995; 182
Li, Kim, Li, Zaia, Yee, Anderson (CR78) 2005; 12
Kim, Cheng, Lindsley, Yang, Cheng (CR106) 2005; 6
Wang, Xu, Sullivan, Souder, Argyris, Acheampong (CR136) 2005; 115
Han, Lin, An, Xu, Yang, O’Connell (CR33) 2008; 4
Weng, Araki, Subedi (CR54) 2012; 12
Williams, Chen, Kwon, Ruiz-Jarabo, Verdin, Greene (CR31) 2006; 25
Fernandez Larrosa, Croci, Riva, Bibini, Luzzi, Saracco (CR101) 2008; 5
Micheva-Viteva, Kobayashi, Edelstein, Pacchia, Lee, Graci (CR139) 2011; 286
Yang, Xing, Shan, O’Connell, Dinoso, Shen (CR47) 2009; 119
Pace, Agosto, Graf, O’Doherty (CR34) 2011; 411
Huber, Doyon, Plaks, Fyne, Mellors, Sluis-Cremer (CR116) 2011; 286
Wang, Ragupathy, Zhao, Hewlett (CR52) 2011; 414
Victoriano, Imai, Togami, Ueno, Asamitsu, Suzuki (CR122) 2011; 585
Trushin, Carena, Bren, Rizza, Dong, Abraham (CR59) 2012; 189
Li, Jiang, Tapping (CR110) 2010; 49
C Tornatore (BFcddis2013248_CR28) 1994; 44
S Matalon (BFcddis2013248_CR121) 2010; 54
NW Cummins (BFcddis2013248_CR55) 2010; 1
L Zheng (BFcddis2013248_CR18) 2007; 50
S Saleh (BFcddis2013248_CR46) 2007; 110
A Savarino (BFcddis2013248_CR118) 2009; 6
L Galluzzi (BFcddis2013248_CR11) 2008; 4
MJ Pace (BFcddis2013248_CR34) 2011; 411
A Bosque (BFcddis2013248_CR68) 2011; 7
A Saez-Cirion (BFcddis2013248_CR60) 2013; 9
BFcddis2013248_CR64
BFcddis2013248_CR62
KG Lassen (BFcddis2013248_CR44) 2012; 7
S Micheva-Viteva (BFcddis2013248_CR139) 2011; 286
D Finzi (BFcddis2013248_CR22) 1999; 5
DC Montefiori (BFcddis2013248_CR113) 1987; 84
NM Archin (BFcddis2013248_CR120) 2009; 23
EE Perez (BFcddis2013248_CR69) 2008; 26
BS Choi (BFcddis2013248_CR119) 2010; 24
H Hatano (BFcddis2013248_CR87) 2012; 208
S Pallikkuth (BFcddis2013248_CR99) 2011; 29
JJ Zaunders (BFcddis2013248_CR58) 2006; 80
AF Victoriano (BFcddis2013248_CR122) 2011; 585
V Klichko (BFcddis2013248_CR132) 2006; 80
NM Archin (BFcddis2013248_CR48) 2009; 25
EJ Duh (BFcddis2013248_CR35) 1989; 86
GD Bren (BFcddis2013248_CR53) 2008; 3
F Wightman (BFcddis2013248_CR26) 2010; 202
J He (BFcddis2013248_CR29) 1997; 385
MR Lopez-Huertas (BFcddis2013248_CR15) 2013; 288
MG Lewis (BFcddis2013248_CR115) 2011; 25
PU Cameron (BFcddis2013248_CR45) 2010; 107
RA Seder (BFcddis2013248_CR95) 1995; 182
F Aillet (BFcddis2013248_CR51) 1998; 72
RJ Brentjens (BFcddis2013248_CR76) 2011; 118
Y Levy (BFcddis2013248_CR92) 2009; 119
BFcddis2013248_CR49
HC Yang (BFcddis2013248_CR47) 2009; 119
SG Deeks (BFcddis2013248_CR30) 2012; 12
J Scholler (BFcddis2013248_CR77) 2012; 4
L Shan (BFcddis2013248_CR67) 2012; 36
Y Han (BFcddis2013248_CR33) 2008; 4
M Dokmanovic (BFcddis2013248_CR40) 2005; 96
S Reuse (BFcddis2013248_CR117) 2009; 4
JJ Lum (BFcddis2013248_CR13) 2003; 1
TW Chun (BFcddis2013248_CR39) 1997; 387
J Chehimi (BFcddis2013248_CR19) 2010; 84
R Liu (BFcddis2013248_CR81) 1996; 86
RT Gandhi (BFcddis2013248_CR89) 2010; 7
J Yuan (BFcddis2013248_CR70) 2012; 20
G Caron (BFcddis2013248_CR111) 2005; 175
M Dean (BFcddis2013248_CR80) 1996; 273
G Fernandez (BFcddis2013248_CR126) 2010; 7
Y Lai (BFcddis2013248_CR71) 2012; 7
TJ Sayers (BFcddis2013248_CR107) 2011; 60
AM Chinnaiyan (BFcddis2013248_CR50) 1997; 3
BFcddis2013248_CR137
J Embretson (BFcddis2013248_CR25) 1993; 362
TM Folks (BFcddis2013248_CR36) 1987; 238
BFcddis2013248_CR138
M Gyrd-Hansen (BFcddis2013248_CR103) 2010; 10
BFcddis2013248_CR6
TW Chun (BFcddis2013248_CR91) 1999; 401
A Marini (BFcddis2013248_CR42) 2008; 181
JL Cho (BFcddis2013248_CR7) 2012; 189
S Xing (BFcddis2013248_CR134) 2011; 85
NM Archin (BFcddis2013248_CR63) 2012; 487
K Huber (BFcddis2013248_CR116) 2011; 286
WY Lam (BFcddis2013248_CR9) 2011; 8
I Sereti (BFcddis2013248_CR93) 2009; 113
G Hutter (BFcddis2013248_CR3) 2011; 25
DJ Schnepple (BFcddis2013248_CR20) 2011; 286
G Strauss (BFcddis2013248_CR109) 2003; 171
AB Balazs (BFcddis2013248_CR73) 2012; 481
M Sadelain (BFcddis2013248_CR75) 2009; 21
DL DiGiusto (BFcddis2013248_CR79) 2010; 2
H Spiegel (BFcddis2013248_CR27) 1992; 140
BFcddis2013248_CR124
BFcddis2013248_CR129
C Banerjee (BFcddis2013248_CR135) 2012; 92
F Pereyra (BFcddis2013248_CR83) 2010; 330
TW Chun (BFcddis2013248_CR24) 2008; 197
T Shishido (BFcddis2013248_CR133) 2012; 86
W Weis (BFcddis2013248_CR5) 1988; 333
SA Williams (BFcddis2013248_CR31) 2006; 25
S Lodi (BFcddis2013248_CR61) 2012; 172
JJ Lum (BFcddis2013248_CR96) 2004; 78
M Veselinovic (BFcddis2013248_CR74) 2012; 432
D Kim (BFcddis2013248_CR106) 2005; 6
AD Badley (BFcddis2013248_CR14) 1999; 6
T Pierson (BFcddis2013248_CR23) 2000; 18
W Bernhard (BFcddis2013248_CR128) 2011; 585
S Saleh (BFcddis2013248_CR130) 2011; 8
L Conti (BFcddis2013248_CR16) 1998; 187
O Kutsch (BFcddis2013248_CR38) 2002; 76
S Mukherjee (BFcddis2013248_CR8) 2012; 9
BFcddis2013248_CR90
N Reddy (BFcddis2013248_CR104) 2010; 21
X Wang (BFcddis2013248_CR52) 2011; 414
Y Levy (BFcddis2013248_CR94) 2012; 55
A Jordan (BFcddis2013248_CR37) 2003; 22
AS Azmi (BFcddis2013248_CR102) 2011; 16
YM Mueller (BFcddis2013248_CR97) 2008; 180
L Shan (BFcddis2013248_CR41) 2011; 85
X Li (BFcddis2013248_CR110) 2010; 49
SA Trushin (BFcddis2013248_CR59) 2012; 189
FX Wang (BFcddis2013248_CR136) 2005; 115
M Samson (BFcddis2013248_CR82) 1996; 382
M Perez (BFcddis2013248_CR131) 2010; 8
S Pallikkuth (BFcddis2013248_CR98) 2012; 32
AC Mita (BFcddis2013248_CR105) 2008; 14
JC Burnett (BFcddis2013248_CR43) 2010; 84
PN Fernandez Larrosa (BFcddis2013248_CR101) 2008; 5
BFcddis2013248_CR86
MR Lopez-Huertas (BFcddis2013248_CR21) 2013; 288
B Taiwo (BFcddis2013248_CR88) 2013; 63
TA Rasmussen (BFcddis2013248_CR123) 2013; 9
M Altmann (BFcddis2013248_CR12) 2005; 3
SA Migueles (BFcddis2013248_CR85) 2008; 29
F Guidi (BFcddis2013248_CR114) 2012; 8
G Hutter (BFcddis2013248_CR2) 2009; 360
K Allers (BFcddis2013248_CR1) 2010; 117
S Thibault (BFcddis2013248_CR112) 2009; 389
M Stremlau (BFcddis2013248_CR72) 2005; 79
NP Weng (BFcddis2013248_CR54) 2012; 12
L Conti (BFcddis2013248_CR100) 2000; 165
MJ Li (BFcddis2013248_CR78) 2005; 12
R Berro (BFcddis2013248_CR17) 2007; 282
H Ying (BFcddis2013248_CR125) 2012; 7
M Shehu-Xhilaga (BFcddis2013248_CR66) 2009; 23
BFcddis2013248_CR65
Y Suzuki (BFcddis2013248_CR4) 1986; 261
P Loetscher (BFcddis2013248_CR57) 1998; 391
MP Martin (BFcddis2013248_CR84) 2007; 39
X Han (BFcddis2013248_CR10) 2012; 7
H Unsoeld (BFcddis2013248_CR56) 2005; 79
C Treand (BFcddis2013248_CR32) 2006; 25
S Bouchat (BFcddis2013248_CR127) 2012; 26
Z Nie (BFcddis2013248_CR108) 2007; 81
15046251 - Curr HIV Res. 2003 Jul;1(3):261-74
23089590 - J Infect Dis. 2013 Jul;208(1):50-6
16277553 - PLoS Biol. 2005 Dec;3(12):e404
19775907 - Cytokine. 2010 Jan;49(1):1-9
21992606 - Retrovirology. 2011;8:80
19327974 - Curr Opin Immunol. 2009 Apr;21(2):215-23
19564922 - PLoS One. 2009;4(6):e6093
16034093 - J Immunol. 2005 Aug 1;175(3):1551-7
22553251 - Sci Transl Med. 2012 May 2;4(132):132ra53
21051598 - Science. 2010 Dec 10;330(6010):1551-7
23324661 - AIDS. 2013 May 15;27(8):1199-208
20979453 - J Infect Dis. 2010 Dec 1;202(11):1738-48
19017960 - J Immunol. 2008 Dec 1;181(11):7713-20
9811703 - J Virol. 1998 Dec;72(12):9698-705
21998586 - PLoS Pathog. 2011 Oct;7(10):e1002288
22486585 - Curr Stem Cell Res Ther. 2012 Jul;7(4):310-7
23166597 - PLoS One. 2012;7(11):e48832
8751444 - Nature. 1996 Aug 22;382(6593):722-5
18097036 - J Immunol. 2008 Jan 1;180(1):350-60
23216614 - Crit Rev Immunol. 2012;32(2):173-95
15709033 - J Virol. 2005 Mar;79(5):3139-45
20133382 - Ann Oncol. 2010 Sep;21(9):1756-64
9450746 - Nature. 1998 Jan 22;391(6665):344-5
3374584 - Nature. 1988 Jun 2;333(6172):426-31
22273578 - Mol Ther. 2012 Apr;20(4):849-59
9449720 - J Exp Med. 1998 Feb 2;187(3):403-13
21173593 - AIDS. 2011 Jan 14;25(2):273-4
16370391 - Curr Opin Investig Drugs. 2005 Dec;6(12):1250-8
23139776 - PLoS One. 2012;7(11):e48340
21859711 - J Biol Chem. 2011 Oct 14;286(41):35742-54
20042498 - J Virol. 2010 Mar;84(6):2762-73
21148083 - Blood. 2011 Mar 10;117(10):2791-9
20651737 - Nat Rev Cancer. 2010 Aug;10(8):561-74
23392463 - J Acquir Immune Defic Syndr. 2013 May 1;63(1):101-4
17005693 - J Virol. 2006 Oct;80(20):10162-72
15141001 - J Virol. 2004 Jun;78(11):6033-42
3782153 - J Biol Chem. 1986 Dec 25;261(36):17057-61
16319923 - EMBO J. 2006 Jan 11;25(1):139-49
22406268 - Immunity. 2012 Mar 23;36(3):491-501
20711481 - PLoS Med. 2010;7(8). pii: e1000321. doi: 10.1371/journal.pmed.1000321
18587387 - Nat Biotechnol. 2008 Jul;26(7):808-16
21498519 - J Biol Chem. 2011 Jun 17;286(24):21083-91
17496894 - Nat Genet. 2007 Jun;39(6):733-40
9024664 - Nature. 1997 Feb 13;385(6617):645-9
19590405 - AIDS. 2009 Sep 10;23(14):1799-806
20154582 - AIDS. 2010 Feb 20;24(4):609-11
1530997 - Am J Pathol. 1992 Jan;140(1):15-22
22134777 - Mol Biosyst. 2012 Apr;8(4):985-93
9144289 - Nature. 1997 May 8;387(6629):183-8
8791590 - Science. 1996 Sep 27;273(5283):1856-62
15767451 - J Virol. 2005 Apr;79(7):4510-3
21284992 - Virology. 2011 Mar 15;411(2):344-54
18260759 - J Infect Dis. 2008 Mar 1;197(5):714-20
19062316 - Immunity. 2008 Dec 19;29(6):1009-21
22550117 - Clin Infect Dis. 2012 Jul;55(2):291-300
21368875 - Cell Death Dis. 2010;1:e99
16611917 - J Virol. 2006 May;80(9):4570-9
18516228 - PLoS Pathog. 2008 May;4(5):e1000018
20812891 - Expert Opin Emerg Drugs. 2011 Mar;16(1):59-70
10553903 - Nature. 1999 Oct 28;401(6756):874-5
21531716 - J Biol Chem. 2011 Jun 24;286(25):22211-8
20300007 - J Acquir Immune Defic Syndr. 2010 May 1;54(1):1-9
9055863 - Nat Med. 1997 Mar;3(3):333-7
23370291 - Hum Vaccin Immunother. 2013 May;9(5):993-1001
21996099 - Vaccine. 2011 Nov 15;29(49):9229-38
10229227 - Nat Med. 1999 May;5(5):512-7
22555163 - AIDS. 2012 Jul 31;26(12):1473-82
19213682 - N Engl J Med. 2009 Feb 12;360(7):692-8
18261236 - Retrovirology. 2008;5:19
16088937 - J Cell Biochem. 2005 Oct 1;96(2):293-304
18461165 - PLoS One. 2008;3(5):e2112
23516360 - PLoS Pathog. 2013 Mar;9(3):e1003211
10837072 - Annu Rev Immunol. 2000;18:665-708
3313729 - Science. 1987 Nov 6;238(4828):800-2
19486542 - Retrovirology. 2009;6:52
16115802 - Mol Ther. 2005 Nov;12(5):900-9
21626033 - Cancer Immunol Immunother. 2011 Aug;60(8):1173-80
22139420 - Nature. 2012 Jan 5;481(7379):81-4
19239360 - AIDS Res Hum Retroviruses. 2009 Feb;25(2):207-12
17356300 - Intervirology. 2007;50(3):224-8
20555022 - Sci Transl Med. 2010 Jun 16;2(36):36ra43
20636281 - Curr HIV Res. 2010 Sep;8(6):418-29
19380868 - Blood. 2009 Jun 18;113(25):6304-14
8096068 - Nature. 1993 Mar 25;362(6418):359-62
15630452 - J Clin Invest. 2005 Jan;115(1):128-37
18698017 - Clin Cancer Res. 2008 Aug 15;14(16):5000-5
19609198 - AIDS. 2009 Sep 24;23(15):2047-50
12682019 - EMBO J. 2003 Apr 15;22(8):1868-77
2762307 - Proc Natl Acad Sci U S A. 1989 Aug;86(15):5974-8
19287090 - J Clin Invest. 2009 Apr;119(4):997-1007
12874203 - J Immunol. 2003 Aug 1;171(3):1172-82
22866982 - Virol J. 2012;9:149
19805909 - J Clin Invest. 2009 Nov;119(11):3473-86
22802411 - J Immunol. 2012 Aug 15;189(4):1835-42
17442709 - J Virol. 2007 Jul;81(13):6947-56
22696646 - J Virol. 2012 Sep;86(17):9055-69
22875804 - J Immunol. 2012 Sep 15;189(6):2879-89
21402072 - FEBS Lett. 2011 Apr 6;585(7):1103-11
16601680 - EMBO J. 2006 Apr 19;25(8):1690-9
12163598 - J Virol. 2002 Sep;76(17):8776-86
8145919 - Neurology. 1994 Mar;44(3 Pt 1):481-7
20942961 - Virol J. 2010;7:266
22832125 - Virology. 2012 Oct 25;432(2):505-10
23364796 - J Biol Chem. 2013 Mar 15;288(11):7626-44
10975846 - J Immunol. 2000 Sep 15;165(6):3293-300
22291913 - PLoS One. 2012;7(1):e30176
22421787 - Nat Rev Immunol. 2012 Apr;12(4):306-15
22826124 - Arch Intern Med. 2012 Sep 10;172(16):1252-5
22020221 - FEBS Lett. 2011 Nov 16;585(22):3549-54
19447460 - Virology. 2009 Jun 20;389(1-2):20-5
21945613 - Biochem Biophys Res Commun. 2011 Oct 14;414(1):20-4
8756719 - Cell. 1996 Aug 9;86(3):367-77
17881634 - Blood. 2007 Dec 15;110(13):4161-4
20837531 - Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16934-9
18692773 - Cell Host Microbe. 2008 Aug 14;4(2):134-46
22814509 - Nat Rev Immunol. 2012 Aug;12(8):607-14
3106982 - Proc Natl Acad Sci U S A. 1987 May;84(9):2985-9
17237230 - J Biol Chem. 2007 Mar 16;282(11):8207-18
7561680 - J Exp Med. 1995 Oct 1;182(4):1067-77
20357084 - J Virol. 2010 Jun;84(12):5958-74
21505294 - AIDS. 2011 Jul 17;25(11):1347-56
22837004 - Nature. 2012 Jul 26;487(7408):482-5
23195410 - Genomics. 2013 Feb;101(2):101-12
10381636 - Cell Death Differ. 1999 May;6(5):420-32
21430059 - J Virol. 2011 Jun;85(11):5384-93
21849486 - Blood. 2011 Nov 3;118(18):4817-28
22802445 - J Leukoc Biol. 2012 Dec;92(6):1147-54
22185562 - Virol J. 2011;8:554
21471244 - J Virol. 2011 Jun;85(12):6060-4
References_xml – volume: 165
  start-page: 3293
  year: 2000
  end-page: 3300
  ident: CR100
  article-title: Dual role of the HIV-1 vpr protein in the modulation of the apoptotic response of T cells
  publication-title: J Immunol
  doi: 10.4049/jimmunol.165.6.3293
– volume: 411
  start-page: 344
  year: 2011
  end-page: 354
  ident: CR34
  article-title: HIV reservoirs and latency models
  publication-title: Virology
  doi: 10.1016/j.virol.2010.12.041
– ident: CR138
– volume: 238
  start-page: 800
  year: 1987
  end-page: 802
  ident: CR36
  article-title: Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line
  publication-title: Science
  doi: 10.1126/science.3313729
– volume: 7
  start-page: 266
  year: 2010
  ident: CR126
  article-title: Cell line-dependent variability in HIV activation employing DNMT inhibitors
  publication-title: Virol J
  doi: 10.1186/1743-422X-7-266
– volume: 6
  start-page: 52
  year: 2009
  ident: CR118
  article-title: "Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-6-52
– volume: 107
  start-page: 16934
  year: 2010
  end-page: 16939
  ident: CR45
  article-title: Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1002894107
– volume: 1
  start-page: 261
  year: 2003
  end-page: 274
  ident: CR13
  article-title: Resistance to apoptosis: mechanism for the development of HIV reservoirs
  publication-title: Curr HIV Res
  doi: 10.2174/1570162033485203
– volume: 288
  start-page: 7626
  year: 2013
  end-page: 7644
  ident: CR15
  article-title: The presence of HIV-1 Tat second exon delays Fas-mediated apoptosis in CD4+ T lymphocytes: a potential mechanism for persistent viral production
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M112.408294
– volume: 8
  start-page: 554
  year: 2011
  ident: CR9
  article-title: Apoptosis, cytokine and chemokine induction by non-structural 1 (NS1) proteins encoded by different influenza subtypes
  publication-title: Virol J
  doi: 10.1186/1743-422X-8-554
– ident: CR129
– volume: 23
  start-page: 2047
  year: 2009
  end-page: 2050
  ident: CR66
  article-title: The novel histone deacetylase inhibitors metacept-1 and metacept-3 potently increase HIV-1 transcription in latently infected cells
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e328330342c
– volume: 362
  start-page: 359
  year: 1993
  end-page: 362
  ident: CR25
  article-title: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS
  publication-title: Nature
  doi: 10.1038/362359a0
– volume: 79
  start-page: 4510
  year: 2005
  end-page: 4513
  ident: CR56
  article-title: Complex memory T-cell phenotypes revealed by coexpression of CD62L and CCR7
  publication-title: J Virol
  doi: 10.1128/JVI.79.7.4510-4513.2005
– volume: 119
  start-page: 997
  year: 2009
  end-page: 1007
  ident: CR92
  article-title: Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment
  publication-title: J Clin Invest
– volume: 55
  start-page: 291
  year: 2012
  end-page: 300
  ident: CR94
  article-title: Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized, placebo-controlled, multicenter study
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cis383
– volume: 187
  start-page: 403
  year: 1998
  end-page: 413
  ident: CR16
  article-title: The HIV-1 vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line: possible implications for the pathogenesis of AIDS
  publication-title: J Exp Med
  doi: 10.1084/jem.187.3.403
– volume: 84
  start-page: 2762
  year: 2010
  end-page: 2773
  ident: CR19
  article-title: Inability of plasmacytoid dendritic cells to directly lyse HIV-infected autologous CD4+ T cells despite induction of tumor necrosis factor-related apoptosis-inducing ligand
  publication-title: J Virol
  doi: 10.1128/JVI.01350-09
– volume: 182
  start-page: 1067
  year: 1995
  end-page: 1077
  ident: CR95
  article-title: Cytokine interactions in human immunodeficiency virus-infected individuals: roles of interleukin (IL)-2, IL-12, and IL-15
  publication-title: J Exp Med
  doi: 10.1084/jem.182.4.1067
– volume: 21
  start-page: 215
  year: 2009
  end-page: 223
  ident: CR75
  article-title: The promise and potential pitfalls of chimeric antigen receptors
  publication-title: Curr Opin Immunol
  doi: 10.1016/j.coi.2009.02.009
– volume: 1
  start-page: e99
  year: 2010
  ident: CR55
  article-title: Mechanisms of HIV-associated lymphocyte apoptosis: 2010
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2010.77
– volume: 92
  start-page: 1147
  year: 2012
  end-page: 1154
  ident: CR135
  article-title: BET bromodomain inhibition as a novel strategy for reactivation of HIV-1
  publication-title: J Leukoc Biol
  doi: 10.1189/jlb.0312165
– volume: 330
  start-page: 1551
  year: 2010
  end-page: 1557
  ident: CR83
  article-title: The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
  publication-title: Science
  doi: 10.1126/science.1195271
– volume: 6
  start-page: 1250
  year: 2005
  end-page: 1258
  ident: CR106
  article-title: Targeting the phosphatidylinositol-3 kinase/Akt pathway for the treatment of cancer
  publication-title: Curr Opin Investig Drugs
– volume: 4
  start-page: e6093
  year: 2009
  ident: CR117
  article-title: Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0006093
– volume: 360
  start-page: 692
  year: 2009
  end-page: 698
  ident: CR2
  article-title: Long-term control of HIV by CCR5 Δ32/Δ32 stem-cell transplantation
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0802905
– volume: 487
  start-page: 482
  year: 2012
  end-page: 485
  ident: CR63
  article-title: Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
  publication-title: Nature
  doi: 10.1038/nature11286
– volume: 10
  start-page: 561
  year: 2010
  end-page: 574
  ident: CR103
  article-title: IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc2889
– volume: 117
  start-page: 2791
  year: 2010
  end-page: 2799
  ident: CR1
  article-title: Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation
  publication-title: Blood
  doi: 10.1182/blood-2010-09-309591
– volume: 86
  start-page: 367
  year: 1996
  end-page: 377
  ident: CR81
  article-title: Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)80110-5
– volume: 2
  start-page: 36ra43
  year: 2010
  ident: CR79
  article-title: RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.3000931
– volume: 208
  start-page: 50
  year: 2012
  end-page: 56
  ident: CR87
  article-title: Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jis630
– volume: 7
  start-page: e30176
  year: 2012
  ident: CR44
  article-title: A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0030176
– volume: 60
  start-page: 1173
  year: 2011
  end-page: 1180
  ident: CR107
  article-title: Targeting the extrinsic apoptosis signaling pathway for cancer therapy
  publication-title: Cancer Immunol Immunother
  doi: 10.1007/s00262-011-1008-4
– volume: 86
  start-page: 9055
  year: 2012
  end-page: 9069
  ident: CR133
  article-title: Selected drugs with reported secondary cell-differentiating capacity prime latent HIV-1 infection for reactivation
  publication-title: J Virol
  doi: 10.1128/JVI.00793-12
– volume: 8
  start-page: 418
  year: 2010
  end-page: 429
  ident: CR131
  article-title: Bryostatin-1 synergizes with histone deacetylase inhibitors to reactivate HIV-1 from latency
  publication-title: Curr HIV Res
  doi: 10.2174/157016210793499312
– volume: 8
  start-page: 985
  year: 2012
  end-page: 993
  ident: CR114
  article-title: 2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds
  publication-title: Mol Biosyst
  doi: 10.1039/C1MB05386H
– volume: 414
  start-page: 20
  year: 2011
  end-page: 24
  ident: CR52
  article-title: Molecules from apoptotic pathways modulate HIV-1 replication in Jurkat cells
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2011.09.007
– volume: 79
  start-page: 3139
  year: 2005
  end-page: 3145
  ident: CR72
  article-title: Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction
  publication-title: J Virol
  doi: 10.1128/JVI.79.5.3139-3145.2005
– ident: CR137
– volume: 389
  start-page: 20
  year: 2009
  end-page: 25
  ident: CR112
  article-title: TLR5 stimulation is sufficient to trigger reactivation of latent HIV-1 provirus in T lymphoid cells and activate virus gene expression in central memory CD4+ T cells
  publication-title: Virology
  doi: 10.1016/j.virol.2009.04.019
– ident: CR6
– volume: 189
  start-page: 2879
  year: 2012
  end-page: 2889
  ident: CR7
  article-title: Enhanced Tim3 activity improves survival after influenza infection
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1102483
– volume: 72
  start-page: 9698
  year: 1998
  end-page: 9705
  ident: CR51
  article-title: Human immunodeficiency virus induces a dual regulation of Bcl-2, resulting in persistent infection of CD4(+) T- or monocytic cell lines
  publication-title: J Virol
– volume: 80
  start-page: 10162
  year: 2006
  end-page: 10172
  ident: CR58
  article-title: Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection
  publication-title: J Virol
  doi: 10.1128/JVI.00249-06
– volume: 76
  start-page: 8776
  year: 2002
  end-page: 8786
  ident: CR38
  article-title: Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency
  publication-title: J Virol
  doi: 10.1128/JVI.76.17.8776-8786.2002
– volume: 382
  start-page: 722
  year: 1996
  end-page: 725
  ident: CR82
  article-title: Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
  publication-title: Nature
  doi: 10.1038/382722a0
– ident: CR86
– volume: 85
  start-page: 6060
  year: 2011
  end-page: 6064
  ident: CR134
  article-title: Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation
  publication-title: J Virol
  doi: 10.1128/JVI.02033-10
– volume: 50
  start-page: 224
  year: 2007
  end-page: 228
  ident: CR18
  article-title: HIV Tat protein increases Bcl-2 expression in monocytes which inhibits monocyte apoptosis induced by tumor necrosis factor-alpha-related apoptosis-induced ligand
  publication-title: Intervirology
  doi: 10.1159/000100565
– volume: 110
  start-page: 4161
  year: 2007
  end-page: 4164
  ident: CR46
  article-title: CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T cells to HIV-1 infection: a novel model of HIV-1 latency
  publication-title: Blood
  doi: 10.1182/blood-2007-06-097907
– volume: 78
  start-page: 6033
  year: 2004
  end-page: 6042
  ident: CR96
  article-title: Differential effects of interleukin-7 and interleukin-15 on NK cell anti-human immunodeficiency virus activity
  publication-title: J Virol
  doi: 10.1128/JVI.78.11.6033-6042.2004
– volume: 16
  start-page: 59
  year: 2011
  end-page: 70
  ident: CR102
  article-title: Emerging Bcl-2 inhibitors for the treatment of cancer
  publication-title: Expert Opin Emerg Drugs
  doi: 10.1517/14728214.2010.515210
– volume: 9
  start-page: 5
  year: 2013
  ident: CR123
  article-title: Comparison of HDAC inhibitors in clinical development: Effect on HIV production in latently infected cells and T-cell activation
  publication-title: Hum Vaccin Immunother
– volume: 118
  start-page: 4817
  year: 2011
  end-page: 4828
  ident: CR76
  article-title: Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
  publication-title: Blood
  doi: 10.1182/blood-2011-04-348540
– volume: 26
  start-page: 808
  year: 2008
  end-page: 816
  ident: CR69
  article-title: Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt1410
– volume: 20
  start-page: 849
  year: 2012
  end-page: 859
  ident: CR70
  article-title: Zinc-finger nuclease editing of human cxcr4 promotes HIV-1 CD4(+) T cell resistance and enrichment
  publication-title: Mol Ther
  doi: 10.1038/mt.2011.310
– volume: 21
  start-page: 1756
  year: 2010
  end-page: 1764
  ident: CR104
  article-title: Enhancing activity and overcoming chemoresistance in hematologic malignancies with bortezomib: preclinical mechanistic studies
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdq009
– volume: 84
  start-page: 5958
  year: 2010
  end-page: 5974
  ident: CR43
  article-title: Combinatorial latency reactivation for HIV-1 subtypes and variants
  publication-title: J Virol
  doi: 10.1128/JVI.00161-10
– volume: 26
  start-page: 1473
  year: 2012
  end-page: 1482
  ident: CR127
  article-title: Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4+ T cells from HIV-1+ HAART-treated patients
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e32835535f5
– volume: 4
  start-page: e1000018
  year: 2008
  ident: CR11
  article-title: Viral control of mitochondrial apoptosis
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1000018
– volume: 25
  start-page: 139
  year: 2006
  end-page: 149
  ident: CR31
  article-title: NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation
  publication-title: EMBO J
  doi: 10.1038/sj.emboj.7600900
– volume: 25
  start-page: 207
  year: 2009
  end-page: 212
  ident: CR48
  article-title: Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid
  publication-title: AIDS Res Hum Retroviruses
  doi: 10.1089/aid.2008.0191
– volume: 3
  start-page: 333
  year: 1997
  end-page: 337
  ident: CR50
  article-title: The inhibition of pro-apoptotic ICE-like proteases enhances HIV replication
  publication-title: Nat Med
  doi: 10.1038/nm0397-333
– volume: 585
  start-page: 3549
  year: 2011
  end-page: 3554
  ident: CR128
  article-title: The Suv39H1 methyltransferase inhibitor chaetocin causes induction of integrated HIV-1 without producing a T cell response
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2011.10.018
– volume: 54
  start-page: 1
  year: 2010
  end-page: 9
  ident: CR121
  article-title: The histone deacetylase inhibitor ITF2357 decreases surface CXCR4 and CCR5 expression on CD4(+) T-cells and monocytes and is superior to valproic acid for latent HIV-1 expression in vitro
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/QAI.0b013e3181d3dca3
– volume: 7
  start-page: e1002288
  year: 2011
  ident: CR68
  article-title: Homeostatic proliferation fails to efficiently reactivate HIV-1 latently infected central memory CD4+ T cells
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1002288
– volume: 286
  start-page: 22211
  year: 2011
  end-page: 22218
  ident: CR116
  article-title: Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.180224
– volume: 25
  start-page: 1347
  year: 2011
  end-page: 1356
  ident: CR115
  article-title: Gold drug auranofin restricts the viral reservoir in the monkey AIDS model and induces containment of viral load following ART suspension
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e328347bd77
– volume: 25
  start-page: 1690
  year: 2006
  end-page: 1699
  ident: CR32
  article-title: Requirement for SWI/SNF chromatin-remodeling complex in Tat-mediated activation of the HIV-1 promoter
  publication-title: EMBO J
  doi: 10.1038/sj.emboj.7601074
– volume: 23
  start-page: 1799
  year: 2009
  end-page: 1806
  ident: CR120
  article-title: Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e32832ec1dc
– ident: CR49
– volume: 39
  start-page: 733
  year: 2007
  end-page: 740
  ident: CR84
  article-title: Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1
  publication-title: Nat Genet
  doi: 10.1038/ng2035
– volume: 175
  start-page: 1551
  year: 2005
  end-page: 1557
  ident: CR111
  article-title: Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+ T cells
  publication-title: J Immunol
  doi: 10.4049/jimmunol.175.3.1551
– volume: 29
  start-page: 9229
  year: 2011
  end-page: 9238
  ident: CR99
  article-title: Interleukin-21 administration to rhesus macaques chronically infected with simian immunodeficiency virus increases cytotoxic effector molecules in T cells and NK cells and enhances B cell function without increasing immune activation or viral replication
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2011.09.118
– volume: 80
  start-page: 4570
  year: 2006
  end-page: 4579
  ident: CR132
  article-title: Hexamethylbisacetamide remodels the human immunodeficiency virus type 1 (HIV-1) promoter and induces Tat-independent HIV-1 expression but blunts cell activation
  publication-title: J Virol
  doi: 10.1128/JVI.80.9.4570-4579.2006
– volume: 86
  start-page: 5974
  year: 1989
  end-page: 5978
  ident: CR35
  article-title: Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.86.15.5974
– volume: 286
  start-page: 35742
  year: 2011
  end-page: 35754
  ident: CR20
  article-title: Isolation of a TRAIL antagonist from the serum of HIV-infected patients
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M111.274639
– volume: 8
  start-page: 80
  year: 2011
  ident: CR130
  article-title: Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4+ T cells
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-8-80
– volume: 12
  start-page: 607
  year: 2012
  end-page: 614
  ident: CR30
  article-title: Towards an HIV cure: a global scientific strategy
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri3262
– volume: 481
  start-page: 81
  year: 2012
  end-page: 84
  ident: CR73
  article-title: Antibody-based protection against HIV infection by vectored immunoprophylaxis
  publication-title: Nature
  doi: 10.1038/nature10660
– volume: 180
  start-page: 350
  year: 2008
  end-page: 360
  ident: CR97
  article-title: IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses
  publication-title: J Immunol
  doi: 10.4049/jimmunol.180.1.350
– volume: 7
  start-page: e48340
  year: 2012
  ident: CR10
  article-title: Influenza virus A/Beijing/501/2009(H1N1) NS1 interacts with beta-tubulin and induces disruption of the microtubule network and apoptosis on A549 cells
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0048340
– volume: 113
  start-page: 6304
  year: 2009
  end-page: 6314
  ident: CR93
  article-title: IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection
  publication-title: Blood
  doi: 10.1182/blood-2008-10-186601
– volume: 401
  start-page: 874
  year: 1999
  end-page: 875
  ident: CR91
  article-title: Re-emergence of HIV after stopping therapy
  publication-title: Nature
  doi: 10.1038/44755
– volume: 24
  start-page: 609
  year: 2010
  end-page: 611
  ident: CR119
  article-title: Novel histone deacetylase inhibitors CG05 and CG06 effectively reactivate latently infected HIV-1
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e328333bfa1
– volume: 12
  start-page: 306
  year: 2012
  end-page: 315
  ident: CR54
  article-title: The molecular basis of the memory T cell response: differential gene expression and its epigenetic regulation
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri3173
– volume: 7
  start-page: e48832
  year: 2012
  ident: CR125
  article-title: Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0048832
– volume: 4
  start-page: 134
  year: 2008
  end-page: 146
  ident: CR33
  article-title: Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2008.06.008
– volume: 432
  start-page: 505
  year: 2012
  end-page: 510
  ident: CR74
  article-title: Topical gel formulation of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 confers protection against HIV-1 vaginal challenge in a humanized mouse model
  publication-title: Virology
  doi: 10.1016/j.virol.2012.06.025
– volume: 3
  start-page: e404
  year: 2005
  ident: CR12
  article-title: Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis
  publication-title: PLoS Biol
  doi: 10.1371/journal.pbio.0030404
– volume: 18
  start-page: 665
  year: 2000
  end-page: 708
  ident: CR23
  article-title: Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.immunol.18.1.665
– volume: 25
  start-page: 273
  year: 2011
  end-page: 274
  ident: CR3
  article-title: Allogeneic transplantation of CCR5-deficient progenitor cells in a patient with HIV infection: an update after 3 years and the search for patient no. 2
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e328340fe28
– volume: 9
  start-page: 149
  year: 2012
  ident: CR8
  article-title: Non structural protein of avian influenza A (H11N1) virus is a weaker suppressor of immune responses but capable of inducing apoptosis in host cells
  publication-title: Virol J
  doi: 10.1186/1743-422X-9-149
– volume: 44
  start-page: 481
  issue: 3 Pt 1
  year: 1994
  end-page: 487
  ident: CR28
  article-title: HIV-1 infection of subcortical astrocytes in the pediatric central nervous system
  publication-title: Neurology
  doi: 10.1212/WNL.44.3_Part_1.481
– volume: 119
  start-page: 3473
  year: 2009
  end-page: 3486
  ident: CR47
  article-title: Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation
  publication-title: J Clin Invest
– volume: 261
  start-page: 17057
  year: 1986
  end-page: 17061
  ident: CR4
  article-title: Human influenza A virus hemagglutinin distinguishes sialyloligosaccharides in membrane-associated gangliosides as its receptor which mediates the adsorption and fusion processes of virus infection. Specificity for oligosaccharides and sialic acids and the sequence to which sialic acid is attached
  publication-title: J Biol Chem
– volume: 288
  start-page: 7626
  year: 2013
  end-page: 7644
  ident: CR21
  article-title: The presence of HIV-1 Tat protein second exon delays Fas protein-mediated apoptosis in CD4+ T lymphocytes: a potential mechanism for persistent viral production
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M112.408294
– volume: 22
  start-page: 1868
  year: 2003
  end-page: 1877
  ident: CR37
  article-title: HIV reproducibly establishes a latent infection after acute infection of T cells in vitro
  publication-title: EMBO J
  doi: 10.1093/emboj/cdg188
– volume: 96
  start-page: 293
  year: 2005
  end-page: 304
  ident: CR40
  article-title: Prospects: histone deacetylase inhibitors
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.20532
– volume: 3
  start-page: e2112
  year: 2008
  ident: CR53
  article-title: Infected cell killing by HIV-1 protease promotes NF-kappaB dependent HIV-1 replication
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0002112
– volume: 140
  start-page: 15
  year: 1992
  end-page: 22
  ident: CR27
  article-title: Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells
  publication-title: Am J Pathol
– volume: 171
  start-page: 1172
  year: 2003
  end-page: 1182
  ident: CR109
  article-title: Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells
  publication-title: J Immunol
  doi: 10.4049/jimmunol.171.3.1172
– volume: 115
  start-page: 128
  year: 2005
  end-page: 137
  ident: CR136
  article-title: IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART
  publication-title: J Clin Invest
  doi: 10.1172/JCI200522574
– volume: 5
  start-page: 512
  year: 1999
  end-page: 517
  ident: CR22
  article-title: Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
  publication-title: Nat Med
  doi: 10.1038/8394
– volume: 387
  start-page: 183
  year: 1997
  end-page: 188
  ident: CR39
  article-title: Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
  publication-title: Nature
  doi: 10.1038/387183a0
– volume: 29
  start-page: 1009
  year: 2008
  end-page: 1021
  ident: CR85
  article-title: Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control
  publication-title: Immunity
  doi: 10.1016/j.immuni.2008.10.010
– volume: 282
  start-page: 8207
  year: 2007
  end-page: 8218
  ident: CR17
  article-title: Identifying the membrane proteome of HIV-1 latently infected cells
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M606324200
– volume: 81
  start-page: 6947
  year: 2007
  end-page: 6956
  ident: CR108
  article-title: Human immunodeficiency virus type 1 protease cleaves procaspase 8 in vivo
  publication-title: J Virol
  doi: 10.1128/JVI.02798-06
– volume: 49
  start-page: 1
  year: 2010
  end-page: 9
  ident: CR110
  article-title: Toll-like receptor signaling in cell proliferation and survival
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2009.08.010
– ident: CR64
– volume: 14
  start-page: 5000
  year: 2008
  end-page: 5005
  ident: CR105
  article-title: Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-08-0746
– volume: 7
  start-page: e1000321
  year: 2010
  ident: CR89
  article-title: The effect of Raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial
  publication-title: PLoS Med
  doi: 10.1371/journal.pmed.1000321
– volume: 6
  start-page: 420
  year: 1999
  end-page: 432
  ident: CR14
  article-title: Dynamic correlation of apoptosis and immune activation during treatment of HIV infection
  publication-title: Cell Death Differ
  doi: 10.1038/sj.cdd.4400509
– volume: 385
  start-page: 645
  year: 1997
  end-page: 649
  ident: CR29
  article-title: CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia
  publication-title: Nature
  doi: 10.1038/385645a0
– volume: 85
  start-page: 5384
  year: 2011
  end-page: 5393
  ident: CR41
  article-title: Influence of host gene transcription level and orientation on HIV-1 latency in a primary-cell model
  publication-title: J Virol
  doi: 10.1128/JVI.02536-10
– volume: 84
  start-page: 2985
  year: 1987
  end-page: 2989
  ident: CR113
  article-title: Antiviral activity of mismatched double-stranded RNA against human immunodeficiency virus in vitro
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.84.9.2985
– volume: 286
  start-page: 21083
  year: 2011
  end-page: 21091
  ident: CR139
  article-title: High-throughput screening uncovers a compound that activates latent HIV-1 and acts cooperatively with a histone deacetylase (HDAC) inhibitor
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.195537
– volume: 181
  start-page: 7713
  year: 2008
  end-page: 7720
  ident: CR42
  article-title: An in vitro system to model the establishment and reactivation of HIV-1 latency
  publication-title: J Immunol
  doi: 10.4049/jimmunol.181.11.7713
– volume: 4
  start-page: 132ra53
  year: 2012
  ident: CR77
  article-title: Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.3003761
– volume: 585
  start-page: 1103
  year: 2011
  end-page: 1111
  ident: CR122
  article-title: Novel histone deacetylase inhibitor NCH-51 activates latent HIV-1 gene expression
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2011.03.017
– volume: 197
  start-page: 714
  year: 2008
  end-page: 720
  ident: CR24
  article-title: Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy
  publication-title: J Infect Dis
  doi: 10.1086/527324
– volume: 7
  start-page: 310
  year: 2012
  end-page: 317
  ident: CR71
  article-title: CCR5-targeted hematopoietic stem cell gene approaches for HIV disease: current progress and future prospects
  publication-title: Curr Stem Cell Res Ther
  doi: 10.2174/157488812800793108
– volume: 202
  start-page: 1738
  year: 2010
  end-page: 1748
  ident: CR26
  article-title: Both CD31(+) and CD31(−) naive CD4(+) T cells are persistent HIV type 1-infected reservoirs in individuals receiving antiretroviral therapy
  publication-title: J Infect Dis
  doi: 10.1086/656721
– ident: CR124
– volume: 189
  start-page: 1835
  year: 2012
  end-page: 1842
  ident: CR59
  article-title: SDF-1alpha degrades whereas glycoprotein 120 upregulates Bcl-2 interacting mediator of death extralong isoform: implications for the development of T cell memory
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1100275
– volume: 9
  start-page: e1003211
  year: 2013
  ident: CR60
  article-title: Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1003211
– volume: 36
  start-page: 491
  year: 2012
  end-page: 501
  ident: CR67
  article-title: Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation
  publication-title: Immunity
  doi: 10.1016/j.immuni.2012.01.014
– volume: 391
  start-page: 344
  year: 1998
  end-page: 345
  ident: CR57
  article-title: CCR5 is characteristic of Th1 lymphocytes
  publication-title: Nature
  doi: 10.1038/34814
– ident: CR65
– ident: CR90
– volume: 63
  start-page: 101
  year: 2013
  end-page: 104
  ident: CR88
  article-title: CD8+ T-cell activation in HIV-1-infected patients experiencing transient low-level viremia during antiretroviral therapy
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/QAI.0b013e3182895af4
– volume: 273
  start-page: 1856
  year: 1996
  end-page: 1862
  ident: CR80
  article-title: Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study
  publication-title: Science
  doi: 10.1126/science.273.5283.1856
– volume: 12
  start-page: 900
  year: 2005
  end-page: 909
  ident: CR78
  article-title: Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy
  publication-title: Mol Ther
  doi: 10.1016/j.ymthe.2005.07.524
– volume: 172
  start-page: 1252
  year: 2012
  end-page: 1255
  ident: CR61
  article-title: Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion
  publication-title: Arch Intern Med
  doi: 10.1001/archinternmed.2012.2719
– volume: 333
  start-page: 426
  year: 1988
  end-page: 431
  ident: CR5
  article-title: Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid
  publication-title: Nature
  doi: 10.1038/333426a0
– ident: CR62
– volume: 32
  start-page: 173
  year: 2012
  end-page: 195
  ident: CR98
  article-title: Role of IL-21 and IL-21 receptor on B cells in HIV infection
  publication-title: Crit Rev Immunol
  doi: 10.1615/CritRevImmunol.v32.i2.50
– volume: 5
  start-page: 19
  year: 2008
  ident: CR101
  article-title: Apoptosis resistance in HIV-1 persistently-infected cells is independent of active viral replication and involves modulation of the apoptotic mitochondrial pathway
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-5-19
– volume: 487
  start-page: 482
  year: 2012
  ident: BFcddis2013248_CR63
  publication-title: Nature
  doi: 10.1038/nature11286
– volume: 110
  start-page: 4161
  year: 2007
  ident: BFcddis2013248_CR46
  publication-title: Blood
  doi: 10.1182/blood-2007-06-097907
– volume: 3
  start-page: 333
  year: 1997
  ident: BFcddis2013248_CR50
  publication-title: Nat Med
  doi: 10.1038/nm0397-333
– volume: 118
  start-page: 4817
  year: 2011
  ident: BFcddis2013248_CR76
  publication-title: Blood
  doi: 10.1182/blood-2011-04-348540
– volume: 282
  start-page: 8207
  year: 2007
  ident: BFcddis2013248_CR17
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M606324200
– volume: 3
  start-page: e404
  year: 2005
  ident: BFcddis2013248_CR12
  publication-title: PLoS Biol
  doi: 10.1371/journal.pbio.0030404
– volume: 22
  start-page: 1868
  year: 2003
  ident: BFcddis2013248_CR37
  publication-title: EMBO J
  doi: 10.1093/emboj/cdg188
– volume: 6
  start-page: 52
  year: 2009
  ident: BFcddis2013248_CR118
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-6-52
– volume: 197
  start-page: 714
  year: 2008
  ident: BFcddis2013248_CR24
  publication-title: J Infect Dis
  doi: 10.1086/527324
– volume: 238
  start-page: 800
  year: 1987
  ident: BFcddis2013248_CR36
  publication-title: Science
  doi: 10.1126/science.3313729
– volume: 202
  start-page: 1738
  year: 2010
  ident: BFcddis2013248_CR26
  publication-title: J Infect Dis
  doi: 10.1086/656721
– volume: 26
  start-page: 1473
  year: 2012
  ident: BFcddis2013248_CR127
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e32835535f5
– volume: 4
  start-page: e1000018
  year: 2008
  ident: BFcddis2013248_CR11
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1000018
– volume: 7
  start-page: e1002288
  year: 2011
  ident: BFcddis2013248_CR68
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1002288
– ident: BFcddis2013248_CR64
– volume: 180
  start-page: 350
  year: 2008
  ident: BFcddis2013248_CR97
  publication-title: J Immunol
  doi: 10.4049/jimmunol.180.1.350
– volume: 10
  start-page: 561
  year: 2010
  ident: BFcddis2013248_CR103
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc2889
– volume: 14
  start-page: 5000
  year: 2008
  ident: BFcddis2013248_CR105
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-08-0746
– volume: 29
  start-page: 1009
  year: 2008
  ident: BFcddis2013248_CR85
  publication-title: Immunity
  doi: 10.1016/j.immuni.2008.10.010
– volume: 25
  start-page: 1690
  year: 2006
  ident: BFcddis2013248_CR32
  publication-title: EMBO J
  doi: 10.1038/sj.emboj.7601074
– volume: 481
  start-page: 81
  year: 2012
  ident: BFcddis2013248_CR73
  publication-title: Nature
  doi: 10.1038/nature10660
– volume: 25
  start-page: 273
  year: 2011
  ident: BFcddis2013248_CR3
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e328340fe28
– volume: 117
  start-page: 2791
  year: 2010
  ident: BFcddis2013248_CR1
  publication-title: Blood
  doi: 10.1182/blood-2010-09-309591
– ident: BFcddis2013248_CR129
  doi: 10.1371/journal.ppat.1004071
– volume: 119
  start-page: 997
  year: 2009
  ident: BFcddis2013248_CR92
  publication-title: J Clin Invest
– volume: 50
  start-page: 224
  year: 2007
  ident: BFcddis2013248_CR18
  publication-title: Intervirology
  doi: 10.1159/000100565
– volume: 54
  start-page: 1
  year: 2010
  ident: BFcddis2013248_CR121
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/QAI.0b013e3181d3dca3
– volume: 165
  start-page: 3293
  year: 2000
  ident: BFcddis2013248_CR100
  publication-title: J Immunol
  doi: 10.4049/jimmunol.165.6.3293
– volume: 12
  start-page: 306
  year: 2012
  ident: BFcddis2013248_CR54
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri3173
– volume: 288
  start-page: 7626
  year: 2013
  ident: BFcddis2013248_CR15
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M112.408294
– volume: 79
  start-page: 4510
  year: 2005
  ident: BFcddis2013248_CR56
  publication-title: J Virol
  doi: 10.1128/JVI.79.7.4510-4513.2005
– volume: 115
  start-page: 128
  year: 2005
  ident: BFcddis2013248_CR136
  publication-title: J Clin Invest
  doi: 10.1172/JCI200522574
– volume: 86
  start-page: 5974
  year: 1989
  ident: BFcddis2013248_CR35
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.86.15.5974
– volume: 81
  start-page: 6947
  year: 2007
  ident: BFcddis2013248_CR108
  publication-title: J Virol
  doi: 10.1128/JVI.02798-06
– volume: 286
  start-page: 22211
  year: 2011
  ident: BFcddis2013248_CR116
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.180224
– volume: 60
  start-page: 1173
  year: 2011
  ident: BFcddis2013248_CR107
  publication-title: Cancer Immunol Immunother
  doi: 10.1007/s00262-011-1008-4
– volume: 8
  start-page: 554
  year: 2011
  ident: BFcddis2013248_CR9
  publication-title: Virol J
  doi: 10.1186/1743-422X-8-554
– volume: 585
  start-page: 3549
  year: 2011
  ident: BFcddis2013248_CR128
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2011.10.018
– volume: 63
  start-page: 101
  year: 2013
  ident: BFcddis2013248_CR88
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/QAI.0b013e3182895af4
– volume: 7
  start-page: e30176
  year: 2012
  ident: BFcddis2013248_CR44
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0030176
– volume: 29
  start-page: 9229
  year: 2011
  ident: BFcddis2013248_CR99
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2011.09.118
– volume: 8
  start-page: 80
  year: 2011
  ident: BFcddis2013248_CR130
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-8-80
– volume: 273
  start-page: 1856
  year: 1996
  ident: BFcddis2013248_CR80
  publication-title: Science
  doi: 10.1126/science.273.5283.1856
– volume: 32
  start-page: 173
  year: 2012
  ident: BFcddis2013248_CR98
  publication-title: Crit Rev Immunol
  doi: 10.1615/CritRevImmunol.v32.i2.50
– volume: 39
  start-page: 733
  year: 2007
  ident: BFcddis2013248_CR84
  publication-title: Nat Genet
  doi: 10.1038/ng2035
– ident: BFcddis2013248_CR137
– ident: BFcddis2013248_CR65
– volume: 414
  start-page: 20
  year: 2011
  ident: BFcddis2013248_CR52
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2011.09.007
– volume: 76
  start-page: 8776
  year: 2002
  ident: BFcddis2013248_CR38
  publication-title: J Virol
  doi: 10.1128/JVI.76.17.8776-8786.2002
– volume: 9
  start-page: 5
  year: 2013
  ident: BFcddis2013248_CR123
  publication-title: Hum Vaccin Immunother
– ident: BFcddis2013248_CR86
  doi: 10.1097/QAD.0b013e32835ecb8b
– volume: 92
  start-page: 1147
  year: 2012
  ident: BFcddis2013248_CR135
  publication-title: J Leukoc Biol
  doi: 10.1189/jlb.0312165
– volume: 1
  start-page: 261
  year: 2003
  ident: BFcddis2013248_CR13
  publication-title: Curr HIV Res
  doi: 10.2174/1570162033485203
– volume: 140
  start-page: 15
  year: 1992
  ident: BFcddis2013248_CR27
  publication-title: Am J Pathol
– ident: BFcddis2013248_CR138
  doi: 10.1186/1758-2652-13-S3-O15
– volume: 72
  start-page: 9698
  year: 1998
  ident: BFcddis2013248_CR51
  publication-title: J Virol
  doi: 10.1128/JVI.72.12.9698-9705.1998
– volume: 8
  start-page: 985
  year: 2012
  ident: BFcddis2013248_CR114
  publication-title: Mol Biosyst
  doi: 10.1039/C1MB05386H
– volume: 36
  start-page: 491
  year: 2012
  ident: BFcddis2013248_CR67
  publication-title: Immunity
  doi: 10.1016/j.immuni.2012.01.014
– volume: 20
  start-page: 849
  year: 2012
  ident: BFcddis2013248_CR70
  publication-title: Mol Ther
  doi: 10.1038/mt.2011.310
– volume: 4
  start-page: 134
  year: 2008
  ident: BFcddis2013248_CR33
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2008.06.008
– volume: 333
  start-page: 426
  year: 1988
  ident: BFcddis2013248_CR5
  publication-title: Nature
  doi: 10.1038/333426a0
– volume: 7
  start-page: e48832
  year: 2012
  ident: BFcddis2013248_CR125
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0048832
– ident: BFcddis2013248_CR62
– volume: 5
  start-page: 19
  year: 2008
  ident: BFcddis2013248_CR101
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-5-19
– volume: 181
  start-page: 7713
  year: 2008
  ident: BFcddis2013248_CR42
  publication-title: J Immunol
  doi: 10.4049/jimmunol.181.11.7713
– volume: 189
  start-page: 1835
  year: 2012
  ident: BFcddis2013248_CR59
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1100275
– volume: 23
  start-page: 2047
  year: 2009
  ident: BFcddis2013248_CR66
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e328330342c
– volume: 286
  start-page: 35742
  year: 2011
  ident: BFcddis2013248_CR20
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M111.274639
– ident: BFcddis2013248_CR90
– volume: 12
  start-page: 607
  year: 2012
  ident: BFcddis2013248_CR30
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri3262
– volume: 7
  start-page: e48340
  year: 2012
  ident: BFcddis2013248_CR10
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0048340
– volume: 16
  start-page: 59
  year: 2011
  ident: BFcddis2013248_CR102
  publication-title: Expert Opin Emerg Drugs
  doi: 10.1517/14728214.2010.515210
– volume: 25
  start-page: 1347
  year: 2011
  ident: BFcddis2013248_CR115
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e328347bd77
– volume: 6
  start-page: 420
  year: 1999
  ident: BFcddis2013248_CR14
  publication-title: Cell Death Differ
  doi: 10.1038/sj.cdd.4400509
– volume: 411
  start-page: 344
  year: 2011
  ident: BFcddis2013248_CR34
  publication-title: Virology
  doi: 10.1016/j.virol.2010.12.041
– volume: 172
  start-page: 1252
  year: 2012
  ident: BFcddis2013248_CR61
  publication-title: Arch Intern Med
  doi: 10.1001/archinternmed.2012.2719
– volume: 5
  start-page: 512
  year: 1999
  ident: BFcddis2013248_CR22
  publication-title: Nat Med
  doi: 10.1038/8394
– volume: 25
  start-page: 139
  year: 2006
  ident: BFcddis2013248_CR31
  publication-title: EMBO J
  doi: 10.1038/sj.emboj.7600900
– volume: 182
  start-page: 1067
  year: 1995
  ident: BFcddis2013248_CR95
  publication-title: J Exp Med
  doi: 10.1084/jem.182.4.1067
– volume: 360
  start-page: 692
  year: 2009
  ident: BFcddis2013248_CR2
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0802905
– volume: 432
  start-page: 505
  year: 2012
  ident: BFcddis2013248_CR74
  publication-title: Virology
  doi: 10.1016/j.virol.2012.06.025
– volume: 7
  start-page: 310
  year: 2012
  ident: BFcddis2013248_CR71
  publication-title: Curr Stem Cell Res Ther
  doi: 10.2174/157488812800793108
– volume: 119
  start-page: 3473
  year: 2009
  ident: BFcddis2013248_CR47
  publication-title: J Clin Invest
– volume: 12
  start-page: 900
  year: 2005
  ident: BFcddis2013248_CR78
  publication-title: Mol Ther
  doi: 10.1016/j.ymthe.2005.07.524
– volume: 6
  start-page: 1250
  year: 2005
  ident: BFcddis2013248_CR106
  publication-title: Curr Opin Investig Drugs
– volume: 288
  start-page: 7626
  year: 2013
  ident: BFcddis2013248_CR21
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M112.408294
– volume: 44
  start-page: 481
  issue: 3 Pt 1
  year: 1994
  ident: BFcddis2013248_CR28
  publication-title: Neurology
  doi: 10.1212/WNL.44.3_Part_1.481
– volume: 86
  start-page: 367
  year: 1996
  ident: BFcddis2013248_CR81
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)80110-5
– volume: 401
  start-page: 874
  year: 1999
  ident: BFcddis2013248_CR91
  publication-title: Nature
  doi: 10.1038/44755
– volume: 21
  start-page: 1756
  year: 2010
  ident: BFcddis2013248_CR104
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdq009
– volume: 391
  start-page: 344
  year: 1998
  ident: BFcddis2013248_CR57
  publication-title: Nature
  doi: 10.1038/34814
– volume: 382
  start-page: 722
  year: 1996
  ident: BFcddis2013248_CR82
  publication-title: Nature
  doi: 10.1038/382722a0
– volume: 49
  start-page: 1
  year: 2010
  ident: BFcddis2013248_CR110
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2009.08.010
– volume: 585
  start-page: 1103
  year: 2011
  ident: BFcddis2013248_CR122
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2011.03.017
– volume: 387
  start-page: 183
  year: 1997
  ident: BFcddis2013248_CR39
  publication-title: Nature
  doi: 10.1038/387183a0
– volume: 2
  start-page: 36ra43
  year: 2010
  ident: BFcddis2013248_CR79
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.3000931
– volume: 80
  start-page: 4570
  year: 2006
  ident: BFcddis2013248_CR132
  publication-title: J Virol
  doi: 10.1128/JVI.80.9.4570-4579.2006
– volume: 385
  start-page: 645
  year: 1997
  ident: BFcddis2013248_CR29
  publication-title: Nature
  doi: 10.1038/385645a0
– volume: 330
  start-page: 1551
  year: 2010
  ident: BFcddis2013248_CR83
  publication-title: Science
  doi: 10.1126/science.1195271
– volume: 261
  start-page: 17057
  year: 1986
  ident: BFcddis2013248_CR4
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(19)75998-5
– volume: 189
  start-page: 2879
  year: 2012
  ident: BFcddis2013248_CR7
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1102483
– volume: 26
  start-page: 808
  year: 2008
  ident: BFcddis2013248_CR69
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt1410
– volume: 24
  start-page: 609
  year: 2010
  ident: BFcddis2013248_CR119
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e328333bfa1
– volume: 18
  start-page: 665
  year: 2000
  ident: BFcddis2013248_CR23
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.immunol.18.1.665
– volume: 362
  start-page: 359
  year: 1993
  ident: BFcddis2013248_CR25
  publication-title: Nature
  doi: 10.1038/362359a0
– volume: 389
  start-page: 20
  year: 2009
  ident: BFcddis2013248_CR112
  publication-title: Virology
  doi: 10.1016/j.virol.2009.04.019
– volume: 4
  start-page: 132ra53
  year: 2012
  ident: BFcddis2013248_CR77
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.3003761
– volume: 25
  start-page: 207
  year: 2009
  ident: BFcddis2013248_CR48
  publication-title: AIDS Res Hum Retroviruses
  doi: 10.1089/aid.2008.0191
– volume: 107
  start-page: 16934
  year: 2010
  ident: BFcddis2013248_CR45
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1002894107
– volume: 3
  start-page: e2112
  year: 2008
  ident: BFcddis2013248_CR53
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0002112
– volume: 23
  start-page: 1799
  year: 2009
  ident: BFcddis2013248_CR120
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e32832ec1dc
– volume: 187
  start-page: 403
  year: 1998
  ident: BFcddis2013248_CR16
  publication-title: J Exp Med
  doi: 10.1084/jem.187.3.403
– volume: 85
  start-page: 5384
  year: 2011
  ident: BFcddis2013248_CR41
  publication-title: J Virol
  doi: 10.1128/JVI.02536-10
– volume: 21
  start-page: 215
  year: 2009
  ident: BFcddis2013248_CR75
  publication-title: Curr Opin Immunol
  doi: 10.1016/j.coi.2009.02.009
– volume: 113
  start-page: 6304
  year: 2009
  ident: BFcddis2013248_CR93
  publication-title: Blood
  doi: 10.1182/blood-2008-10-186601
– ident: BFcddis2013248_CR6
  doi: 10.1016/j.ygeno.2012.11.008
– volume: 7
  start-page: 266
  year: 2010
  ident: BFcddis2013248_CR126
  publication-title: Virol J
  doi: 10.1186/1743-422X-7-266
– volume: 85
  start-page: 6060
  year: 2011
  ident: BFcddis2013248_CR134
  publication-title: J Virol
  doi: 10.1128/JVI.02033-10
– volume: 79
  start-page: 3139
  year: 2005
  ident: BFcddis2013248_CR72
  publication-title: J Virol
  doi: 10.1128/JVI.79.5.3139-3145.2005
– volume: 175
  start-page: 1551
  year: 2005
  ident: BFcddis2013248_CR111
  publication-title: J Immunol
  doi: 10.4049/jimmunol.175.3.1551
– volume: 9
  start-page: e1003211
  year: 2013
  ident: BFcddis2013248_CR60
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1003211
– volume: 171
  start-page: 1172
  year: 2003
  ident: BFcddis2013248_CR109
  publication-title: J Immunol
  doi: 10.4049/jimmunol.171.3.1172
– volume: 208
  start-page: 50
  year: 2012
  ident: BFcddis2013248_CR87
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jis630
– volume: 4
  start-page: e6093
  year: 2009
  ident: BFcddis2013248_CR117
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0006093
– volume: 286
  start-page: 21083
  year: 2011
  ident: BFcddis2013248_CR139
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.195537
– volume: 7
  start-page: e1000321
  year: 2010
  ident: BFcddis2013248_CR89
  publication-title: PLoS Med
  doi: 10.1371/journal.pmed.1000321
– volume: 84
  start-page: 2762
  year: 2010
  ident: BFcddis2013248_CR19
  publication-title: J Virol
  doi: 10.1128/JVI.01350-09
– volume: 96
  start-page: 293
  year: 2005
  ident: BFcddis2013248_CR40
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.20532
– volume: 84
  start-page: 2985
  year: 1987
  ident: BFcddis2013248_CR113
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.84.9.2985
– volume: 8
  start-page: 418
  year: 2010
  ident: BFcddis2013248_CR131
  publication-title: Curr HIV Res
  doi: 10.2174/157016210793499312
– volume: 84
  start-page: 5958
  year: 2010
  ident: BFcddis2013248_CR43
  publication-title: J Virol
  doi: 10.1128/JVI.00161-10
– volume: 78
  start-page: 6033
  year: 2004
  ident: BFcddis2013248_CR96
  publication-title: J Virol
  doi: 10.1128/JVI.78.11.6033-6042.2004
– volume: 1
  start-page: e99
  year: 2010
  ident: BFcddis2013248_CR55
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2010.77
– ident: BFcddis2013248_CR49
– volume: 80
  start-page: 10162
  year: 2006
  ident: BFcddis2013248_CR58
  publication-title: J Virol
  doi: 10.1128/JVI.00249-06
– volume: 86
  start-page: 9055
  year: 2012
  ident: BFcddis2013248_CR133
  publication-title: J Virol
  doi: 10.1128/JVI.00793-12
– ident: BFcddis2013248_CR124
– volume: 9
  start-page: 149
  year: 2012
  ident: BFcddis2013248_CR8
  publication-title: Virol J
  doi: 10.1186/1743-422X-9-149
– volume: 55
  start-page: 291
  year: 2012
  ident: BFcddis2013248_CR94
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cis383
– reference: 21996099 - Vaccine. 2011 Nov 15;29(49):9229-38
– reference: 7561680 - J Exp Med. 1995 Oct 1;182(4):1067-77
– reference: 9055863 - Nat Med. 1997 Mar;3(3):333-7
– reference: 19805909 - J Clin Invest. 2009 Nov;119(11):3473-86
– reference: 20300007 - J Acquir Immune Defic Syndr. 2010 May 1;54(1):1-9
– reference: 19447460 - Virology. 2009 Jun 20;389(1-2):20-5
– reference: 22486585 - Curr Stem Cell Res Ther. 2012 Jul;7(4):310-7
– reference: 10381636 - Cell Death Differ. 1999 May;6(5):420-32
– reference: 23324661 - AIDS. 2013 May 15;27(8):1199-208
– reference: 12682019 - EMBO J. 2003 Apr 15;22(8):1868-77
– reference: 10837072 - Annu Rev Immunol. 2000;18:665-708
– reference: 16370391 - Curr Opin Investig Drugs. 2005 Dec;6(12):1250-8
– reference: 18692773 - Cell Host Microbe. 2008 Aug 14;4(2):134-46
– reference: 22832125 - Virology. 2012 Oct 25;432(2):505-10
– reference: 22837004 - Nature. 2012 Jul 26;487(7408):482-5
– reference: 16319923 - EMBO J. 2006 Jan 11;25(1):139-49
– reference: 3313729 - Science. 1987 Nov 6;238(4828):800-2
– reference: 16611917 - J Virol. 2006 May;80(9):4570-9
– reference: 22291913 - PLoS One. 2012;7(1):e30176
– reference: 23364796 - J Biol Chem. 2013 Mar 15;288(11):7626-44
– reference: 8751444 - Nature. 1996 Aug 22;382(6593):722-5
– reference: 2762307 - Proc Natl Acad Sci U S A. 1989 Aug;86(15):5974-8
– reference: 19609198 - AIDS. 2009 Sep 24;23(15):2047-50
– reference: 20636281 - Curr HIV Res. 2010 Sep;8(6):418-29
– reference: 23166597 - PLoS One. 2012;7(11):e48832
– reference: 23089590 - J Infect Dis. 2013 Jul;208(1):50-6
– reference: 20979453 - J Infect Dis. 2010 Dec 1;202(11):1738-48
– reference: 21531716 - J Biol Chem. 2011 Jun 24;286(25):22211-8
– reference: 19564922 - PLoS One. 2009;4(6):e6093
– reference: 18461165 - PLoS One. 2008;3(5):e2112
– reference: 23139776 - PLoS One. 2012;7(11):e48340
– reference: 17005693 - J Virol. 2006 Oct;80(20):10162-72
– reference: 23216614 - Crit Rev Immunol. 2012;32(2):173-95
– reference: 18698017 - Clin Cancer Res. 2008 Aug 15;14(16):5000-5
– reference: 16115802 - Mol Ther. 2005 Nov;12(5):900-9
– reference: 9450746 - Nature. 1998 Jan 22;391(6665):344-5
– reference: 17496894 - Nat Genet. 2007 Jun;39(6):733-40
– reference: 22550117 - Clin Infect Dis. 2012 Jul;55(2):291-300
– reference: 20133382 - Ann Oncol. 2010 Sep;21(9):1756-64
– reference: 19775907 - Cytokine. 2010 Jan;49(1):1-9
– reference: 21148083 - Blood. 2011 Mar 10;117(10):2791-9
– reference: 17881634 - Blood. 2007 Dec 15;110(13):4161-4
– reference: 18587387 - Nat Biotechnol. 2008 Jul;26(7):808-16
– reference: 16034093 - J Immunol. 2005 Aug 1;175(3):1551-7
– reference: 20154582 - AIDS. 2010 Feb 20;24(4):609-11
– reference: 8756719 - Cell. 1996 Aug 9;86(3):367-77
– reference: 20555022 - Sci Transl Med. 2010 Jun 16;2(36):36ra43
– reference: 21992606 - Retrovirology. 2011;8:80
– reference: 22802411 - J Immunol. 2012 Aug 15;189(4):1835-42
– reference: 21471244 - J Virol. 2011 Jun;85(12):6060-4
– reference: 19327974 - Curr Opin Immunol. 2009 Apr;21(2):215-23
– reference: 22802445 - J Leukoc Biol. 2012 Dec;92(6):1147-54
– reference: 19239360 - AIDS Res Hum Retroviruses. 2009 Feb;25(2):207-12
– reference: 17356300 - Intervirology. 2007;50(3):224-8
– reference: 18261236 - Retrovirology. 2008;5:19
– reference: 10553903 - Nature. 1999 Oct 28;401(6756):874-5
– reference: 19017960 - J Immunol. 2008 Dec 1;181(11):7713-20
– reference: 12874203 - J Immunol. 2003 Aug 1;171(3):1172-82
– reference: 22020221 - FEBS Lett. 2011 Nov 16;585(22):3549-54
– reference: 20837531 - Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16934-9
– reference: 22696646 - J Virol. 2012 Sep;86(17):9055-69
– reference: 21998586 - PLoS Pathog. 2011 Oct;7(10):e1002288
– reference: 22273578 - Mol Ther. 2012 Apr;20(4):849-59
– reference: 21505294 - AIDS. 2011 Jul 17;25(11):1347-56
– reference: 22555163 - AIDS. 2012 Jul 31;26(12):1473-82
– reference: 19287090 - J Clin Invest. 2009 Apr;119(4):997-1007
– reference: 20651737 - Nat Rev Cancer. 2010 Aug;10(8):561-74
– reference: 21173593 - AIDS. 2011 Jan 14;25(2):273-4
– reference: 16601680 - EMBO J. 2006 Apr 19;25(8):1690-9
– reference: 22826124 - Arch Intern Med. 2012 Sep 10;172(16):1252-5
– reference: 19380868 - Blood. 2009 Jun 18;113(25):6304-14
– reference: 21498519 - J Biol Chem. 2011 Jun 17;286(24):21083-91
– reference: 19590405 - AIDS. 2009 Sep 10;23(14):1799-806
– reference: 22406268 - Immunity. 2012 Mar 23;36(3):491-501
– reference: 15141001 - J Virol. 2004 Jun;78(11):6033-42
– reference: 21368875 - Cell Death Dis. 2010;1:e99
– reference: 15630452 - J Clin Invest. 2005 Jan;115(1):128-37
– reference: 3106982 - Proc Natl Acad Sci U S A. 1987 May;84(9):2985-9
– reference: 20357084 - J Virol. 2010 Jun;84(12):5958-74
– reference: 21051598 - Science. 2010 Dec 10;330(6010):1551-7
– reference: 15046251 - Curr HIV Res. 2003 Jul;1(3):261-74
– reference: 1530997 - Am J Pathol. 1992 Jan;140(1):15-22
– reference: 22875804 - J Immunol. 2012 Sep 15;189(6):2879-89
– reference: 22185562 - Virol J. 2011;8:554
– reference: 23195410 - Genomics. 2013 Feb;101(2):101-12
– reference: 3782153 - J Biol Chem. 1986 Dec 25;261(36):17057-61
– reference: 10229227 - Nat Med. 1999 May;5(5):512-7
– reference: 16088937 - J Cell Biochem. 2005 Oct 1;96(2):293-304
– reference: 18097036 - J Immunol. 2008 Jan 1;180(1):350-60
– reference: 21626033 - Cancer Immunol Immunother. 2011 Aug;60(8):1173-80
– reference: 23392463 - J Acquir Immune Defic Syndr. 2013 May 1;63(1):101-4
– reference: 15709033 - J Virol. 2005 Mar;79(5):3139-45
– reference: 21945613 - Biochem Biophys Res Commun. 2011 Oct 14;414(1):20-4
– reference: 18516228 - PLoS Pathog. 2008 May;4(5):e1000018
– reference: 21430059 - J Virol. 2011 Jun;85(11):5384-93
– reference: 17442709 - J Virol. 2007 Jul;81(13):6947-56
– reference: 8145919 - Neurology. 1994 Mar;44(3 Pt 1):481-7
– reference: 9024664 - Nature. 1997 Feb 13;385(6617):645-9
– reference: 10975846 - J Immunol. 2000 Sep 15;165(6):3293-300
– reference: 22421787 - Nat Rev Immunol. 2012 Apr;12(4):306-15
– reference: 22553251 - Sci Transl Med. 2012 May 2;4(132):132ra53
– reference: 23370291 - Hum Vaccin Immunother. 2013 May;9(5):993-1001
– reference: 9811703 - J Virol. 1998 Dec;72(12):9698-705
– reference: 8096068 - Nature. 1993 Mar 25;362(6418):359-62
– reference: 22139420 - Nature. 2012 Jan 5;481(7379):81-4
– reference: 19213682 - N Engl J Med. 2009 Feb 12;360(7):692-8
– reference: 20942961 - Virol J. 2010;7:266
– reference: 22814509 - Nat Rev Immunol. 2012 Aug;12(8):607-14
– reference: 19062316 - Immunity. 2008 Dec 19;29(6):1009-21
– reference: 23516360 - PLoS Pathog. 2013 Mar;9(3):e1003211
– reference: 22134777 - Mol Biosyst. 2012 Apr;8(4):985-93
– reference: 22866982 - Virol J. 2012;9:149
– reference: 17237230 - J Biol Chem. 2007 Mar 16;282(11):8207-18
– reference: 3374584 - Nature. 1988 Jun 2;333(6172):426-31
– reference: 21284992 - Virology. 2011 Mar 15;411(2):344-54
– reference: 16277553 - PLoS Biol. 2005 Dec;3(12):e404
– reference: 20042498 - J Virol. 2010 Mar;84(6):2762-73
– reference: 12163598 - J Virol. 2002 Sep;76(17):8776-86
– reference: 20711481 - PLoS Med. 2010;7(8). pii: e1000321. doi: 10.1371/journal.pmed.1000321
– reference: 9449720 - J Exp Med. 1998 Feb 2;187(3):403-13
– reference: 8791590 - Science. 1996 Sep 27;273(5283):1856-62
– reference: 21402072 - FEBS Lett. 2011 Apr 6;585(7):1103-11
– reference: 9144289 - Nature. 1997 May 8;387(6629):183-8
– reference: 18260759 - J Infect Dis. 2008 Mar 1;197(5):714-20
– reference: 19486542 - Retrovirology. 2009;6:52
– reference: 20812891 - Expert Opin Emerg Drugs. 2011 Mar;16(1):59-70
– reference: 15767451 - J Virol. 2005 Apr;79(7):4510-3
– reference: 21849486 - Blood. 2011 Nov 3;118(18):4817-28
– reference: 21859711 - J Biol Chem. 2011 Oct 14;286(41):35742-54
SSID ssj0000330256
Score 2.2577858
SecondaryResourceType review_article
Snippet Recent cases of successful control of human immunodeficiency virus (HIV) by bone marrow transplant in combination with suppressive antiretroviral therapy (ART)...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e718
SubjectTerms 631/326/596/2558
631/80/82/23
692/699/255/1901
Animals
Anti-HIV Agents - pharmacology
Anti-HIV Agents - therapeutic use
Antibodies
Apoptosis
Biochemistry
Biomedical and Life Sciences
CD4-Positive T-Lymphocytes - physiology
CD4-Positive T-Lymphocytes - virology
Cell Biology
Cell Culture
Cell death
Genetic Therapy
HIV Infections - immunology
HIV Infections - therapy
HIV-1 - physiology
Host-Pathogen Interactions
Human immunodeficiency virus
Humans
Immunology
Immunotherapy
Life Sciences
Review
Virus Latency
SummonAdditionalLinks – databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LSwMxEA5aEbyIb-uLCIJetqab7Gb3IFLEUoV6stLbkldRKFvtA-2_d2Yf1VoVdk-ZQDLJZL7JTGYIOWOWK6Oc8JivtSe0AJGSofM4tzbUDCSK4QPn9kPY6oj7btD9in8qGDj61bTDelKdYb_28Ta9BoG_yp-MR5cGI28wSovXfBEtkxXQShKFtF1A_exUBsMd1HuZt3Gh27xeWgCbizGTPxynmT5qbpD1AkjSRr7ym2TJpVtkNS8tOd0mjQa6waEnxat5ahHpUSw__K6mI6rgS2mZT5yOB9RMho627p5oGZ2V7pBO8_bxpuUV5RI8EwRyDEZgz2cK4JEF1BHGVvQiIVSkmZCBAdFlOtY65ACnmbZSQgNzcLhJrrRR8PNdUkkHqdsnNO4JY3uhiwID5oYPMsxih3XSYx5H1hdV4pXMSkyRSxxLWvSTzKfNoyRjboLMTYC5VXI-o3_Ns2j8SXlU8j4pN0NSl2B3oX-yXiWns2aQA-SgSt1gAjSAtGJQyTL4h0bGYM0CBIYJ7OXLORsOQBcR-j6rEjm30DMCzMM935K-PGf5uLnEOyEY20W5Jb4N_ddZHvw_y0Oy5mdVNzAq-IhUxsOJOwbsM9Yn2ab-BNaiA3s
  priority: 102
  providerName: Scholars Portal
– databaseName: SpringerOpen Free (Free internet resource, activated by CARLI)
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dS8MwEA86EXwRv61OiSDoSzVr0qZ9HMMxBX1ysreSr6EgnbgO2X_vXb9w8wOhfcoFLpe75ne56x0h58xyZZQTPgu09oUWYFIycj7n1kaagUUx_MH5_iEaDMXdKBxVjuK0SqssS1oWn-k6O-zaYHYNZmLxq0DEq2QNy7ajRveiXnOnwsA5hyO8rs3I46Vpi2fPN0D5PS9yKThanDn9LbJZgUXaLdnbJisu2yHrZfvI-S7pdjHUDTMpXr9Ti2iOYovhDzWfUgVPRuua4TSfUAPrpYPbJ1pnYGV7ZNi_eewN_Kolgm_CUObg6I0DpgACWUAWUWLFOBZCxZoJGRowT6YTrSMOkJlpKyUMMAcfMMmVNgpevk9a2SRzh4QmY2HsOHJxaMClCMBOWeKwF3rCk9gGwiN-LazUVPXCsW3Fa1rErXmcFsJNUbgpCNcjFw39W1kp41fKdi37tLKYadqR4FthDLLjkbNmGHQdJagyN5kBDaCpBI5dGf5BIxPwWAHmwgIOyu1s2AF4IqIgYB6RCxvdEGCt7cWR7OW5qLnNJd77AG-XtUp8Yf3HVR79n_SYbARFlw3MAm6TVv4-cyeAdXJ9Wij4Jxnw_cI
  priority: 102
  providerName: Springer Nature
Title Altering cell death pathways as an approach to cure HIV infection
URI https://link.springer.com/article/10.1038/cddis.2013.248
https://www.ncbi.nlm.nih.gov/pubmed/23846220
https://www.proquest.com/docview/1786208991
https://www.proquest.com/docview/1399934175
https://www.proquest.com/docview/1790941504
https://pubmed.ncbi.nlm.nih.gov/PMC3730421
Volume 4
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3rSyMxEB885eC-iI9T66NEELwve8ZNdrP7Sdai1IIieh79tuRVFGSrtkX8753Z7q5voQ9oZiGZZJJfZqbzA9jhTmirvQx4aEwgjUSTUrEPhHAuNhwtitMfnE_P4u6V7PWjfuVwG1VplfWeWG7UbmjJR763rxB7U4xq_-DuPiDWKIquVhQaP2COSpdRSpfqq8bHwvGyjkd6XatRJHuWknQooUv8DYny5_VZ9AFgfsyTfBcsLc-g4wWYr8Ajy6azvQgzvliCn1M6yadlyDIKfeOTjNzxzBG6Y0Q5_KifRkzjq2B1DXE2HjI7efCse_Kf1RlZxW-4Oj761-kGFUVCYKNIjfHiNwi5RkjkEGnEqZODREqdGC5VZNFcuUmNiQVCaG6cUtjAPW5oSmhjNb7FCswWw8KvAUsH0rpB7JPI4hUjRLvlqSdu9FSkiQtlC4JaWbmt6ocTjcVtXsaxRZKXys1JuTkqtwW7jfzdtHLGl5Kbte7zyoJG-ct8t2C7aca1TxrUhR9OUAbRVYrHsIq-kVEp3mAR9uIAVqfT2XQH4YqMw5C3QL2Z6EaAam-_bSlurssa3EKRHwj79qdeEq-6_uko178f5Qb8CkumDcoE3oTZ8cPEbyHeGZt2uajbMJdlvcsefh8enZ1f4K-duNMufQj4eSqTZ0onBjc
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTgheEN8UBhgJBC9hnu3EyQNCBTa1bKsQ2tDegr8qJk3pWFtN_af4G7lL4rAx2Nuk5MmXyD7f2b_zne8AXnIvjTNBJVxYmyirUKV0FhIpvc8sR43idMF5d5wN99Xng_RgBX7FuzAUVhnXxHqh9lNHZ-TrGxqxN_moNt4f_0yoahR5V2MJjUYstsPyFE222bvRJ5zfV0Jsbe59HCZtVYHEpameo600EdwgivC4OWeFV5NcKZNbrnTqUMK5LazNJKJObr3W2MADrgFaGusMvhL_ew1WlURTpgerHzbHX752pzpcSgIRMTukzNcdhQVRCJl8K6jI0Nnd7wKkvRiZ-Zd7tt71tm7DrRauskEjX3dgJVR34XpTwHJ5DwYDcrbjl4wcAMwTnmRU5PjULGfM4FOxmLWczafMLU4CG46-sRgDVt2H_Sth3wPoVdMqPAJWTJTzkyzkqUOjRuBKwYtA1dgLWeReqD4kkVmlazOWU-GMo7L2nMu8rJlbEnNLZG4fXnf0x02ujv9SrkXel63Ozso_EtaHF10zahtx0FRhukAaxHMFbvw6vYRGF2gzI9DGATxsprPrDgIklQnB-6DPTXRHQNm-z7dUhz_qrN9S08kT9u1NFIkzXf_nKB9fPsrncGO4t7tT7ozG20_gpqjrfFAc8hr05ieL8BTR1tw-a0Wcwfer1qrf-Vo-tA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NIRAviG8KA4wEgpdQ13bi5AGhilG1DCYeGOpb8FcEEkrH2mrqv8Zfx10Sh43B3ialT75G9vnO_tl3uR_AM-6lcSaohAtrE2UVupTOQiKl95nl6FGcPnD-uJ9ND9T7eTrfgl_xWxhKq4xrYrNQ-4WjO_LhSCP2phjVaFh1aRGfdidvDn8mxCBFkdZIp9GayF7YHOPxbfl6totz_VyIybvPb6dJxzCQuDTVKzw3VYIbRBQeN-qs8KrKlTK55UqnDq2d28LaTCIC5dZrjQ084HqgpbHO4E_iey_BZS3TEfmYnuv-fodLSXAi1omU-dBRghAlk8lXguiGTu6DZ8Dt2RzNvwK1zf43uQHXO-DKxq2l3YStUN-CKy2V5eY2jMcUdsd_MgoFME_IkhHd8bHZLJnBp2axfjlbLZhbHwU2nX1hMRusvgMHF6K8u7BdL-pwH1hRKeerLOSpw-ONwDWDF4F42QtZ5F6oASRRWaXrapcThcaPsomhy7xslFuScktU7gBe9PKHbdWO_0ruRN2Xnfcuyz-2NoCnfTP6HWnQ1GGxRhlEdgVCAJ2eI6MLPD0j5MYB3Guns-8OQiWVCcEHoE9NdC9Adb9Pt9TfvzX1v6WmOyjs28toEie6_s9RPjh_lE_gKvpS-WG2v_cQromG8IMSkndge3W0Do8Qdq3s48a-GXy9aIf6DT05QYQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Altering+cell+death+pathways+as+an+approach+to+cure+HIV+infection&rft.jtitle=Cell+death+%26+disease&rft.au=Badley%2C+A+D&rft.au=Sainski%2C+A&rft.au=Wightman%2C+F&rft.au=Lewin%2C+S+R&rft.date=2013-07-01&rft.pub=Springer+Nature+B.V&rft.eissn=2041-4889&rft.volume=4&rft.spage=e718&rft_id=info:doi/10.1038%2Fcddis.2013.248&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=4042531961
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-4889&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-4889&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-4889&client=summon